Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Integer Holdings Corporation (ITGR)
USD95.28
+1.97 (+2.11%)
US NYSE Healthcare Medical - Devices
Address
5830 Granite Parkway 75024
Plano, TX, US
Plano, TX, US
CEO
Payman Khales
Website
integer.net
IPO
2000-09-29
CIK 1114483 ISIN US45826H1095
Description
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD95.28
+1.97 (+2.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
525.0K
Beta
0.64
Float Shares
33.86M
Free Float %
98.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.15% | -2.22% | -0.15% | -0.45% | +22.26% | +8.35% | -29.59% | +8.39% | -5.29% | +171.41% | +271.50% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (14 ratings, all time)
Buy
Price Targets & DCF
Current price
95.28
Low
95.00
-0.3%
Consensus
98.00
+2.9%
Median
98.00
+2.9%
High
101.00
+6.0%
DCF (Unlevered)
170.69
+79.1%
DCF (Levered)
68.52
-28.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
101.00
+6.0%
|
| Last Year | 8 |
100.13
+5.1%
|
| All Time | 14 |
118.93
+24.8%
|
Quality scores
Altman Z-Score
2.35
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+7.6% Q2'26: +0.8% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-15.0% Q2'26: +172.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+3.2% Q2'26: +0.2% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+11.3% ★ Q2'26: +8.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+5.5% ★ Q2'26: +3.7% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.2% ★ Q2'26: +1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×4.18× Q2'26: 4.92× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2008 actual |
Dec 2009 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 7 Rev. Ana. 6 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
546.64M
est: 519.39M (+5.2%)
|
521.82M
est: 501.07M (+4.1%)
|
646.18M
est: 660.18M (-2.1%)
|
663.95M
est: 617.74M (+7.5%)
|
687.79M
est: 640.24M (+7.4%)
|
800.41M
est: 810.51M (-1.2%)
|
1.08B
est: 1.38B (-21.9%)
|
1.14B
est: 1.43B (-20.5%)
|
1.22B
est: 1.25B (-3.0%)
|
1.26B
est: 1.25B (+0.3%)
|
1.07B
est: 1.07B (+0.5%)
|
1.22B
est: 1.22B (+0.4%)
|
1.33B
est: 1.36B (-2.5%)
|
1.56B
est: 1.67B (-6.8%)
|
1.72B
est: 1.72B (-0.1%)
|
1.85B
est: 1.84B (+0.1%)
|
1.82B
1.80B – 1.84B
-1.5% YoY
|
1.92B
1.89B – 1.98B
+5.9% YoY
|
2.03B
2.03B – 2.03B
+5.2% YoY
|
2.21B
2.19B – 2.25B
+9.2% YoY
|
| EBITDA |
92.64M
est: 50.34M (+84.0%)
|
49.12M
est: 42.54M (+15.5%)
|
114.54M
est: 73.24M (+56.4%)
|
112.24M
est: 88.13M (+27.4%)
|
130.62M
est: 109.33M (+19.5%)
|
151.56M
est: 144.63M (+4.8%)
|
228.27M
est: 245.83M (-7.1%)
|
243.90M
est: 271.83M (-10.3%)
|
253.15M
est: 333.09M (-24.0%)
|
247.49M
est: 204.00M (+21.3%)
|
182.99M
est: 190.62M (-4.0%)
|
224.65M
est: 216.94M (+3.6%)
|
221.75M
est: 246.10M (-9.9%)
|
275.71M
est: 321.60M (-14.3%)
|
332.94M
est: 331.02M (+0.6%)
|
335.22M
est: 355.46M (-5.7%)
|
350.11M
346.29M – 353.94M
-1.5% YoY
|
370.94M
365.15M – 380.60M
+5.9% YoY
|
390.35M
390.35M – 390.35M
+5.2% YoY
|
426.37M
421.18M – 432.63M
+9.2% YoY
|
| EBIT |
40.47M
est: 20.37M (+98.7%)
|
1.89M
est: -3.26M (+158.0%)
|
68.70M
est: 27.42M (+150.5%)
|
76.27M
est: 55.99M (+36.2%)
|
93.42M
est: 70.08M (+33.3%)
|
106.92M
est: 90.28M (+18.4%)
|
155.40M
est: 153.46M (+1.3%)
|
162.71M
est: 142.11M (+14.5%)
|
171.62M
est: 145.13M (+18.3%)
|
169.60M
est: 133.05M (+27.5%)
|
103.66M
est: 118.99M (-12.9%)
|
143.06M
est: 135.42M (+5.6%)
|
130.85M
est: 160.28M (-18.4%)
|
178.72M
est: 209.13M (-14.5%)
|
223.23M
est: 215.25M (+3.7%)
|
209.27M
est: 231.15M (-9.5%)
|
227.67M
225.19M – 230.16M
-1.5% YoY
|
241.22M
237.45M – 247.50M
+5.9% YoY
|
253.84M
253.84M – 253.84M
+5.2% YoY
|
277.26M
273.89M – 281.33M
+9.2% YoY
|
| Net Income |
18.56M
est: 6.30M (+194.8%)
|
-9.00M
est: -11.87M (+24.1%)
|
-4.80M
est: -3.40M (-41.0%)
|
36.27M
est: 33.38M (+8.6%)
|
55.46M
est: 51.16M (+8.4%)
|
-7.59M
est: 94.83M (-108.0%)
|
5.96M
est: 93.40M (-93.6%)
|
66.68M
est: 53.52M (+24.6%)
|
167.96M
est: 145.88M (+15.1%)
|
96.34M
est: 81.26M (+18.6%)
|
77.26M
est: 82.94M (-6.9%)
|
96.81M
est: 133.68M (-27.6%)
|
66.38M
est: 113.16M (-41.3%)
|
90.65M
est: 112.31M (-19.3%)
|
119.90M
est: 189.91M (-36.9%)
|
102.76M
est: 225.40M (-54.4%)
|
218.28M
208.05M – 228.50M
-3.2% YoY
|
245.50M
231.42M – 259.59M
+12.5% YoY
|
259.37M
254.85M – 263.89M
+5.6% YoY
|
294.36M
289.71M – 299.98M
+13.5% YoY
|
| SGA |
72.63M
est: 73.47M (-1.1%)
|
70.29M
est: 128.20M (-45.2%)
|
80.99M
est: 128.11M (-36.8%)
|
88.97M
est: 96.19M (-7.5%)
|
88.39M
est: 83.68M (+5.6%)
|
98.20M
est: 93.96M (+4.5%)
|
134.38M
est: 159.72M (-15.9%)
|
143.07M
est: 173.81M (-17.7%)
|
142.45M
est: 145.09M (-1.8%)
|
138.88M
est: 128.13M (+8.4%)
|
137.21M
est: 123.85M (+10.8%)
|
141.69M
est: 140.95M (+0.5%)
|
157.36M
est: 140.64M (+11.9%)
|
171.47M
est: 180.20M (-4.8%)
|
184.33M
est: 185.48M (-0.6%)
|
162.59M
est: 199.18M (-18.4%)
|
196.18M
194.04M – 198.33M
-1.5% YoY
|
207.85M
204.60M – 213.26M
+5.9% YoY
|
218.73M
218.73M – 218.73M
+5.2% YoY
|
238.91M
236.00M – 242.42M
+9.2% YoY
|
| EPS |
0.82
est: 0.98 (-16.3%)
|
-0.39
est: 1.39 (-128.1%)
|
-0.20
est: 1.83 (-110.9%)
|
1.51
est: 1.82 (-17.0%)
|
2.23
est: 2.09 (+6.7%)
|
-0.29
est: 2.66 (-110.9%)
|
0.19
est: 2.62 (-92.7%)
|
2.12
est: 2.63 (-19.5%)
|
5.23
est: 3.48 (+50.2%)
|
2.80
est: 4.33 (-35.4%)
|
2.35
est: 2.33 (+1.0%)
|
2.82
est: 3.75 (-24.8%)
|
1.97
est: 3.84 (-48.7%)
|
2.72
est: 3.15 (-13.7%)
|
3.60
est: 5.34 (-32.5%)
|
2.96
est: 6.34 (-53.3%)
|
6.12
5.85 – 6.42
-3.4% YoY
|
6.85
6.50 – 7.29
+11.9% YoY
|
7.28
7.16 – 7.41
+6.2% YoY
|
8.27
8.14 – 8.43
+13.7% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-01 | Piper Sandler | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
176.41M
OE per share TTM
4.95
Owner's Yield
6.07%
Maintenance CapEx ratio
138.76%
Maint CapEx / Avg PPE
30.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
78
Total invested
90.15M
Insider transactions (90d)
0
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 5.61M | 16.90% | — | — | — | — | HC | Delaware | 2023-01-20 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 3.59M | 10.86% | — | 28.0K | 3.53M | 57.3K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 3 | KKR & Co. L.P. | 2.95M | 9.64% | 2.95M | — | 2.95M | — | PN | Delaware | 2015-10-29 | ↗ |
| 4 | KKR Group Holdings L.P. | 2.95M | 9.64% | 2.95M | — | 2.95M | — | PN | Cayman Islands | 2015-10-29 | ↗ |
| 5 | KKR Group Limited | 2.95M | 9.64% | 2.95M | — | 2.95M | — | OO | Cayman Islands | 2015-10-29 | ↗ |
| 6 | (. | 1.97M | 8.40% | 1.92M | — | 1.97M | — | IA | Delaware | 2012-02-14 | ↗ |
| 7 | 30-0447847 | 1.91M | 5.80% | 1.85M | — | 1.91M | — | IA | Delaware | 2021-02-12 | ↗ |
| 8 | BlackRock for purposes of Schedule 13G filings. | 1.75M | 7.54% | 1.75M | — | 1.75M | — | HC | Delaware | 2010-01-29 | ↗ |
| 9 | Wells Fargo & Company | 1.56M | 5.06% | 20.0K | 683.8K | 20.0K | — | HC | Delaware | 2017-01-27 | ↗ |
| 10 | Wells Fargo and Company | 1.32M | 5.68% | 950.9K | 525.00 | 1.32M | — | HC | Delaware | 2011-01-25 | ↗ |
| 11 | Wells Capital Management Incorporated | 1.32M | 5.66% | 418.2K | — | 1.32M | — | IA | Delaware | 2011-01-25 | ↗ |
| 12 | Series | 1.23M | 5.32% | 1.23M | — | 1.23M | — | IC | Maryland | 2010-02-12 | ↗ |
| 13 | Lord, Abbett & Co. LLC | 1.14M | 4.89% | 1.00M | — | 1.14M | — | IA | Delaware | 2010-12-10 | ↗ |
| 14 | Edward C. Johnson 3d | 845.4K | 3.61% | — | — | 845.4K | — | IN | Delaware | 2011-10-11 | ↗ |
| 15 | FMR LLC | 845.4K | 3.61% | 1.8K | — | 845.4K | — | HC | Delaware | 2011-10-11 | ↗ |
| 16 | 23-2772200 | 266.4K | 0.82% | 100.4K | — | 266.4K | — | IA | State of Delaware | 2019-02-13 | ↗ |
| 17 | Accellent Holdings LLC | — | 0.00% | — | — | — | — | OO | Cayman Islands | 2019-02-13 | ↗ |
| 18 | George R. Roberts | — | 0.00% | — | — | — | — | IN | Cayman Islands | 2019-02-13 | ↗ |
| 19 | Henry R. Kravis | — | 0.00% | — | — | — | — | IN | Cayman Islands | 2019-02-13 | ↗ |
| 20 | KKR Associates Millennium L.P. | — | 0.00% | — | — | — | — | PN | Cayman Islands | 2019-02-13 | ↗ |
| 21 | KKR Fund Holdings GP Limited | — | 0.00% | — | — | — | — | OO | Cayman Islands | 2019-02-13 | ↗ |
| 22 | KKR Fund Holdings L.P. | — | 0.00% | — | — | — | — | PN | Cayman Islands | 2019-02-13 | ↗ |
| 23 | KKR Management LLC | — | 0.00% | — | — | — | — | OO | Cayman Islands | 2019-02-13 | ↗ |
| 24 | KKR Millennium Fund L.P. | — | 0.00% | — | — | — | — | PN | Cayman Islands | 2019-02-13 | ↗ |
| 25 | KKR Millennium GP LLC | — | 0.00% | — | — | — | — | OO | Cayman Islands | 2019-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
78
-252 vs prev Q
New positions
8
Closed positions
254
Increased
33
Reduced
24
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 343.2K +343.2K (+100.0%) | 26.92B +26.9B (+100.0%) | 0.98% +0.978 pp | 0.04% +0.041 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 5.29M +168.7K (+3.3%) | 414.66M -114.2M (-21.6%) | 15.07% +0.462 pp | 0.01% -0.002 pp | USD128.38 -38.9% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 3.89M +14.5K (+0.4%) | 304.79M -95.3M (-23.8%) | 11.08% +0.027 pp | 0.00% -0.002 pp | USD46.92 +67.2% | 38 qtrs — |
| 4 | DIMENSIONAL FUND ADVISORS LP | 1.39M -16.4K (-1.2%) | 109.34M -36.4M (-25.0%) | 3.97% -0.052 pp | 0.02% -0.008 pp | USD34.71 +126.0% | 38 qtrs — |
| 5 | STATE STREET CORP | 1.37M +48.5K (+3.7%) | 107.59M -29.1M (-21.3%) | 3.91% +0.133 pp | 0.00% -0.001 pp | USD56.89 +37.9% | 39 qtrs — |
| 6 | INVESCO LTD. | 1.27M +162.8K (+14.7%) | 99.59M -14.8M (-12.9%) | 3.62% +0.460 pp | 0.02% -0.003 pp | USD106.01 -26.0% | 38 qtrs — |
| 7 | IRENIC CAPITAL MANAGEMENT LP | 1.26M +1.3M (+100.0%) | 99.11M +99.1M (+100.0%) | 3.60% +3.602 pp | 6.67% +6.666 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 8 | ALLIANCEBERNSTEIN L.P. | 1.24M -16.4K (-1.3%) | 97.49M -32.7M (-25.1%) | 3.54% -0.052 pp | 0.03% -0.010 pp | USD118.00 -33.5% | 38 qtrs — |
| 9 | EARNEST PARTNERS LLC | 1.06M -21.8K (-2.0%) | 83.50M -28.8M (-25.6%) | 3.03% -0.066 pp | 0.36% -0.129 pp | USD72.24 +8.6% | 13 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 832.9K +3.7K (+0.4%) | 65.34M -20.4M (-23.8%) | 2.37% +0.007 pp | 0.00% -0.001 pp | USD70.20 +11.7% | 38 qtrs — |
| 11 | MORGAN STANLEY | 831.1K -46.4K (-5.3%) | 65.18M -25.5M (-28.1%) | 2.37% -0.136 pp | 0.00% -0.002 pp | USD92.05 -14.8% | 38 qtrs — |
| 12 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 807.0K +401.1K (+98.8%) | 63.29M +21.4M (+50.9%) | 2.30% +1.142 pp | 0.02% +0.007 pp | USD90.95 -13.8% | 2 qtrs — |
| 13 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 704.6K +442.4K (+168.7%) | 55.26M +28.2M (+103.9%) | 2.01% +1.260 pp | 0.05% +0.023 pp | USD91.57 -14.3% | 38 qtrs — |
| 14 | MILLENNIUM MANAGEMENT LLC | 677.1K +657.5K (+3,350.2%) | 53.11M +51.1M (+2,518.8%) | 1.93% +1.874 pp | 0.02% +0.022 pp | USD79.65 -1.5% | 24 qtrs — |
| 15 | COOKE & BIELER LP | 613.1K +228.6K (+59.5%) | 48.09M +8.4M (+21.0%) | 1.75% +0.650 pp | 0.50% +0.091 pp | USD84.87 -7.6% | 12 qtrs — |
| 16 | FRANKLIN RESOURCES INC | 552.4K -326.8K (-37.2%) | 43.32M -47.5M (-52.3%) | 1.57% -0.935 pp | 0.01% -0.012 pp | USD84.13 -6.8% | 38 qtrs — |
| 17 | NEWTYN MANAGEMENT, LLC | 550.0K +550.0K (+100.0%) | 43.14M +43.1M (+100.0%) | 1.57% +1.568 pp | 4.53% +4.532 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 18 | GW&K INVESTMENT MANAGEMENT, LLC | 534.9K +118.8K (+28.6%) | 41.96M -1.0M (-2.4%) | 1.52% +0.337 pp | 0.36% -0.018 pp | USD76.34 +2.7% | 24 qtrs — |
| 19 | J. GOLDMAN & CO LP | 516.8K +516.8K (+100.0%) | 40.53M +40.5M (+100.0%) | 1.47% +1.473 pp | 1.07% +1.067 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 20 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 468.4K +193.0K (+70.1%) | 36.73M +8.3M (+29.1%) | 1.34% +0.549 pp | 0.10% +0.029 pp | USD93.07 -15.7% | 2 qtrs — |
| 21 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 463.9K -229.2K (-33.1%) | 36.39M -35.2M (-49.2%) | 1.32% -0.656 pp | 0.25% -0.224 pp | USD77.19 +1.6% | 30 qtrs — |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 438.0K +29.9K (+7.3%) | 34.35M -7.8M (-18.5%) | 1.25% +0.084 pp | 0.01% -0.001 pp | USD66.19 +18.5% | 38 qtrs — |
| 23 | GOLDMAN SACHS GROUP INC | 437.6K -392.9K (-47.3%) | 34.32M -51.5M (-60.0%) | 1.25% -1.123 pp | 0.00% -0.006 pp | USD98.98 -20.8% | 38 qtrs — |
| 24 | BANK OF AMERICA CORP /DE/ | 436.5K -43.2K (-9.0%) | 34.24M -15.3M (-30.9%) | 1.24% -0.125 pp | 0.00% -0.001 pp | USD104.25 -24.8% | 37 qtrs — |
| 25 | ROYAL BANK OF CANADA | 401.9K -39.1K (-8.9%) | 31.52M -14.0M (-30.8%) | 1.15% -0.113 pp | 0.01% -0.002 pp | USD54.23 +44.6% | 38 qtrs — |
| 26 | NORTHERN TRUST CORP | 400.2K -15.6K (-3.8%) | 31.38M -11.6M (-26.9%) | 1.14% -0.046 pp | 0.00% -0.002 pp | USD61.47 +27.6% | 38 qtrs — |
| 27 | CITADEL ADVISORS LLC | 310.1K +931.0 (+0.3%) | 24.32M -7.6M (-23.9%) | 0.88% +0.002 pp | 0.00% -0.001 pp | USD121.93 -35.7% | 18 qtrs — |
| 28 | KENNEDY CAPITAL MANAGEMENT LLC | 300.5K +300.5K (+100.0%) | 23.57M +23.6M (+100.0%) | 0.86% +0.857 pp | 0.50% +0.499 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 29 | RAYMOND JAMES FINANCIAL INC | 298.8K -31.6K (-9.6%) | 23.41M -10.7M (-31.4%) | 0.85% -0.091 pp | 0.01% -0.004 pp | USD127.80 -38.6% | 5 qtrs — |
| 30 | BALYASNY ASSET MANAGEMENT L.P. | 282.2K +282.2K (+100.0%) | 22.13M +22.1M (+100.0%) | 0.80% +0.804 pp | 0.03% +0.028 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 31 | WESTWOOD HOLDINGS GROUP INC | 282.1K -3.5K (-1.2%) | 22.13M -7.4M (-25.0%) | 0.80% -0.011 pp | 0.18% -0.031 pp | USD98.40 -20.3% | 15 qtrs — |
| 32 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 280.2K +280.1K (+800,382.9%) | 21.97M +22.0M (+549,250.0%) | 0.81% +0.807 pp | 0.01% +0.014 pp | USD78.43 +0.0% | 2 qtrs — |
| 33 | WELLS FARGO & COMPANY/MN | 268.0K -26.2K (-8.9%) | 21.02M -9.4M (-30.8%) | 0.76% -0.076 pp | 0.00% -0.002 pp | USD100.08 -21.6% | 38 qtrs — |
| 34 | FMR LLC | 254.3K -379.3K (-59.9%) | 19.95M -45.5M (-69.5%) | 0.72% -1.084 pp | 0.00% -0.002 pp | USD100.63 -22.1% | 30 qtrs — |
| 35 | HEARTLAND ADVISORS INC | 242.7K +202.7K (+506.8%) | 19.04M +14.9M (+360.6%) | 0.69% +0.578 pp | 1.03% +0.807 pp | USD78.52 -0.1% | 12 qtrs — |
| 36 | NOMURA HOLDINGS INC | 239.5K -38.1K (-13.7%) | 18.79M -9.9M (-34.5%) | 0.68% -0.110 pp | 0.03% -0.019 pp | USD98.94 -20.7% | 12 qtrs — |
| 37 | BANK OF NEW YORK MELLON CORP | 237.4K -10.0K (-4.0%) | 18.62M -6.9M (-27.2%) | 0.68% -0.029 pp | 0.00% -0.002 pp | USD52.57 +49.2% | 38 qtrs — |
| 38 | PALISADE CAPITAL MANAGEMENT, LP | 227.3K +5.1K (+2.3%) | 17.83M -5.1M (-22.4%) | 0.65% +0.014 pp | 0.53% -0.095 pp | USD116.31 -32.6% | 7 qtrs — |
| 39 | TRIBUTARY CAPITAL MANAGEMENT, LLC | 221.6K -28.3K (-11.3%) | 17.38M -8.4M (-32.7%) | 0.63% -0.082 pp | 1.71% -0.624 pp | USD84.20 -6.9% | 27 qtrs — |
| 40 | PRINCIPAL FINANCIAL GROUP INC | 205.8K +12.0K (+6.2%) | 16.14M -3.9M (-19.4%) | 0.59% +0.034 pp | 0.01% -0.002 pp | USD50.75 +54.5% | 38 qtrs — |
| 41 | ENVESTNET ASSET MANAGEMENT INC | 201.8K -32.6K (-13.9%) | 15.83M -8.4M (-34.7%) | 0.58% -0.094 pp | 0.00% -0.002 pp | USD79.08 -0.8% | 38 qtrs — |
| 42 | FULLER & THALER ASSET MANAGEMENT, INC. | 191.2K -56.3K (-22.7%) | 15.00M -10.6M (-41.4%) | 0.55% -0.161 pp | 0.05% -0.036 pp | USD92.50 -15.2% | 27 qtrs — |
| 43 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 187.4K +187.4K (+100.0%) | 14.69M +14.7M (+100.0%) | 0.53% +0.534 pp | 0.05% +0.052 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 44 | AMERIPRISE FINANCIAL INC | 168.5K -745.6K (-81.6%) | 13.22M -81.2M (-86.0%) | 0.48% -2.129 pp | 0.00% -0.019 pp | USD114.70 -31.6% | 39 qtrs — |
| 45 | SEI INVESTMENTS CO | 163.1K -6.9K (-4.1%) | 12.79M -4.8M (-27.2%) | 0.46% -0.020 pp | 0.01% -0.006 pp | USD115.69 -32.2% | 14 qtrs — |
| 46 | UBS GROUP AG | 153.8K -1.9K (-1.2%) | 12.06M -4.0M (-25.0%) | 0.44% -0.006 pp | 0.00% -0.001 pp | USD122.01 -35.7% | 38 qtrs — |
| 47 | BARCLAYS PLC | 148.4K -70.7K (-32.3%) | 11.64M -16.8M (-59.1%) | 0.42% -0.203 pp | 0.00% -0.005 pp | USD93.35 -16.0% | 38 qtrs — |
| 48 | SEA CLIFF PARTNERS MANAGEMENT, LP | 133.0K +133.0K (+100.0%) | 10.43M +10.4M (+100.0%) | 0.38% +0.379 pp | 4.40% +4.396 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 49 | PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 131.8K +— (+0.0%) | 10.34M -3.3M (-24.1%) | 0.38% -0.001 pp | 0.04% -0.012 pp | USD35.03 +123.9% | 38 qtrs — |
| 50 | NORTH GROWTH MANAGEMENT LTD. | 129.0K +26.0K (+25.2%) | 10.15M -442.0K (-4.2%) | 0.37% +0.074 pp | 1.59% -0.257 pp | USD96.87 -19.0% | 9 qtrs — |
| 51 | JANE STREET GROUP, LLC | 121.7K +114.7K (+1,627.9%) | 9.55M +8.8M (+1,211.5%) | 0.35% +0.327 pp | 0.00% +0.001 pp | USD80.15 -2.1% | 14 qtrs — |
| 52 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 121.4K -15.2K (-11.2%) | 9.52M -4.6M (-32.6%) | 0.35% -0.044 pp | 0.03% -0.020 pp | USD100.98 -22.3% | 38 qtrs — |
| 53 | NUVEEN, LLC | 117.6K +34.6K (+41.7%) | 9.22M +644.7K (+7.5%) | 0.34% +0.098 pp | 0.00% +0.000 pp | USD106.37 -26.3% | 4 qtrs — |
| 54 | JPMORGAN CHASE & CO | 110.6K -295.2K (-72.7%) | 8.68M -33.3M (-79.3%) | 0.32% -0.843 pp | 0.00% -0.002 pp | USD120.04 -34.7% | 38 qtrs — |
| 55 | PFM HEALTH SCIENCES, LP | 106.6K +106.6K (+100.0%) | 8.36M +8.4M (+100.0%) | 0.30% +0.304 pp | 0.83% +0.833 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 56 | RHUMBLINE ADVISERS | 104.6K +745.0 (+0.7%) | 8.20M -2.5M (-23.6%) | 0.30% +0.002 pp | 0.01% -0.002 pp | USD59.58 +31.6% | 38 qtrs — |
| 57 | NANTAHALA CAPITAL MANAGEMENT, LLC | 102.0K +102.0K (+100.0%) | 8.00M +8.0M (+100.0%) | 0.29% +0.291 pp | 0.26% +0.265 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 58 | FRED ALGER MANAGEMENT, LLC | 101.8K +101.8K (+100.0%) | 7.98M +8.0M (+100.0%) | 0.29% +0.290 pp | 0.03% +0.031 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 59 | D. E. SHAW & CO., INC. | 97.3K +79.8K (+457.1%) | 7.63M +5.8M (+322.9%) | 0.28% +0.228 pp | 0.00% +0.003 pp | USD85.11 -7.8% | 10 qtrs — |
| 60 | NEW YORK STATE COMMON RETIREMENT FUND | 96.1K -171.5K (-64.1%) | 7.53M -20.1M (-72.8%) | 0.27% -0.490 pp | 0.01% -0.026 pp | USD99.74 -21.4% | 38 qtrs — |
| 61 | CITIGROUP INC | 93.2K +29.0K (+45.2%) | 7.31M +675.3K (+10.2%) | 0.27% +0.082 pp | 0.00% +0.000 pp | USD100.14 -21.7% | 38 qtrs — |
| 62 | DEUTSCHE BANK AG\ | 90.2K +62.5K (+225.7%) | 7.07M +4.2M (+147.2%) | 0.26% +0.178 pp | 0.00% +0.001 pp | USD85.70 -8.5% | 38 qtrs — |
| 63 | LEGAL & GENERAL GROUP PLC | 88.7K -5.0K (-5.4%) | 6.96M -2.7M (-28.2%) | 0.25% -0.015 pp | 0.00% -0.001 pp | USD58.30 +34.5% | 38 qtrs — |
| 64 | UBS ASSET MANAGEMENT AMERICAS INC | 82.2K +5.7K (+7.4%) | 6.45M -1.5M (-18.5%) | 0.23% +0.016 pp | 0.00% 0.000 pp | USD102.60 -23.6% | 38 qtrs — |
| 65 | BANCO SANTANDER, S.A. | 77.9K -30.0K (-27.8%) | 6.11M -5.0M (-45.2%) | 0.22% -0.086 pp | 0.05% -0.053 pp | USD122.24 -35.8% | 3 qtrs — |
| 66 | SQUAREPOINT OPS LLC | 76.8K +18.6K (+31.9%) | 6.02M +7.6K (+0.1%) | 0.22% +0.053 pp | 0.01% +0.000 pp | USD110.30 -28.9% | 6 qtrs — |
| 67 | QUBE RESEARCH & TECHNOLOGIES LTD | 76.7K -17.2K (-18.3%) | 6.02M -3.7M (-38.0%) | 0.22% -0.050 pp | 0.01% -0.004 pp | USD105.44 -25.6% | 6 qtrs — |
| 68 | KESTREL INVESTMENT MANAGEMENT CORP | 75.7K +75.7K (+100.0%) | 5.93M +5.9M (+100.0%) | 0.22% +0.216 pp | 3.36% +3.363 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 69 | TWO SIGMA INVESTMENTS, LP | 74.9K -34.5K (-31.5%) | 5.87M -5.4M (-48.0%) | 0.21% -0.099 pp | 0.01% -0.009 pp | USD121.17 -35.3% | 10 qtrs — |
| 70 | ENGINEERS GATE MANAGER LP | 74.6K +70.3K (+1,619.6%) | 5.85M +5.4M (+1,205.2%) | 0.21% +0.200 pp | 0.07% +0.064 pp | USD81.02 -3.2% | 5 qtrs — |
| 71 | EDGESTREAM PARTNERS, L.P. | 70.8K +10.3K (+17.0%) | 5.55M -701.1K (-11.2%) | 0.20% +0.029 pp | 0.16% -0.027 pp | USD106.57 -26.4% | 6 qtrs — |
| 72 | COLONY GROUP, LLC | 69.9K +37.7K (+117.2%) | 5.48M +2.2M (+66.4%) | 0.20% +0.107 pp | 0.01% +0.001 pp | USD88.84 -11.7% | 9 qtrs — |
| 73 | SWISS NATIONAL BANK | 69.1K +1.4K (+2.1%) | 5.42M -1.6M (-22.5%) | 0.20% +0.004 pp | 0.00% -0.001 pp | USD50.48 +55.4% | 38 qtrs — |
| 74 | VERITION FUND MANAGEMENT LLC | 69.0K +61.7K (+839.4%) | 5.41M +4.7M (+613.0%) | 0.20% +0.176 pp | 0.02% +0.018 pp | USD82.64 -5.1% | 7 qtrs — |
| 75 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 66.0K +66.0K (+100.0%) | 5.17M +5.2M (+100.0%) | 0.19% +0.188 pp | 0.01% +0.009 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 76 | BRIDGEWATER ASSOCIATES, LP | 64.3K +53.5K (+497.4%) | 5.04M +3.9M (+353.4%) | 0.18% +0.153 pp | 0.02% +0.014 pp | USD82.60 -5.0% | 2 qtrs — |
| 77 | F/M INVESTMENTS LLC | 64.1K +13.3K (+26.3%) | 5.03M -216.9K (-4.1%) | 0.18% +0.038 pp | 0.19% -0.011 pp | USD108.39 -27.6% | 7 qtrs — |
| 78 | DANA INVESTMENT ADVISORS, INC. | 63.9K -84.0 (-0.1%) | 5.01M -1.6M (-24.2%) | 0.18% -0.001 pp | 0.15% -0.048 pp | USD115.99 -32.4% | 8 qtrs — |
| 79 | WINTON GROUP LTD | 61.7K +61.7K (+100.0%) | 4.84M +4.8M (+100.0%) | 0.18% +0.176 pp | 0.17% +0.167 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 80 | JACOBS LEVY EQUITY MANAGEMENT, INC | 61.4K +61.4K (+100.0%) | 4.81M +4.8M (+100.0%) | 0.18% +0.175 pp | 0.02% +0.019 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 81 | BNP PARIBAS ARBITRAGE, SNC | 59.6K -59.0K (-49.7%) | 4.68M -7.6M (-61.9%) | 0.17% -0.169 pp | 0.00% -0.004 pp | USD105.94 -26.0% | 38 qtrs — |
| 82 | ASSENAGON ASSET MANAGEMENT S.A. | 59.6K +23.8K (+66.6%) | 4.67M +976.2K (+26.4%) | 0.17% +0.068 pp | 0.01% +0.001 pp | USD105.17 -25.4% | 3 qtrs — |
| 83 | GABELLI FUNDS LLC | 58.7K -19.3K (-24.7%) | 4.60M -3.5M (-42.9%) | 0.17% -0.055 pp | 0.03% -0.023 pp | USD71.44 +9.8% | 38 qtrs — |
| 84 | XTX TOPCO LTD | 58.4K +58.4K (+100.0%) | 4.58M +4.6M (+100.0%) | 0.17% +0.167 pp | 0.12% +0.120 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 85 | LPL FINANCIAL LLC | 49.7K -1.3K (-2.5%) | 3.90M -1.4M (-26.0%) | 0.14% -0.004 pp | 0.00% -0.001 pp | USD100.01 -21.6% | 35 qtrs — |
| 86 | 13D MANAGEMENT LLC | 47.0K +47.0K (+100.0%) | 3.69M +3.7M (+100.0%) | 0.13% +0.134 pp | 4.39% +4.386 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 87 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 46.9K +100.0 (+0.2%) | 3.68M -1.2M (-23.9%) | 0.13% +0.000 pp | 0.01% -0.002 pp | USD34.35 +128.3% | 39 qtrs — |
| 88 | CERITY PARTNERS LLC | 43.7K -74.8K (-63.1%) | 3.43M -8.8M (-72.0%) | 0.12% -0.214 pp | 0.01% -0.015 pp | USD106.30 -26.2% | 9 qtrs — |
| 89 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 42.6K +40.6K (+2,030.0%) | 3.34M +3.1M (+1,516.7%) | 0.12% +0.116 pp | 0.00% +0.000 pp | USD79.99 -2.0% | 20 qtrs — |
| 90 | JEFFERIES FINANCIAL GROUP INC. | 42.0K +42.0K (+100.0%) | 3.29M +3.3M (+100.0%) | 0.12% +0.120 pp | 0.02% +0.017 pp | USD78.43 +0.0% | 1 qtrs NEW |
| 91 | ABRDN PLC | 41.5K -249.6K (-85.7%) | 3.26M -26.2M (-88.9%) | 0.12% -0.713 pp | 0.01% -0.042 pp | USD90.23 -13.1% | 25 qtrs — |
| 92 | QUANTBOT TECHNOLOGIES LP | 41.5K +27.8K (+202.4%) | 3.26M +1.8M (+129.5%) | 0.12% +0.079 pp | 0.11% +0.070 pp | USD93.08 -15.7% | 4 qtrs — |
| 93 | MERCER GLOBAL ADVISORS INC /ADV | 41.0K +555.0 (+1.4%) | 3.22M -964.8K (-23.1%) | 0.12% +0.001 pp | 0.00% -0.002 pp | USD91.63 -14.4% | 26 qtrs — |
| 94 | HOMESTEAD ADVISERS CORP | 40.7K +— (+0.0%) | 3.19M -1.0M (-24.1%) | 0.12% 0.000 pp | 0.08% -0.016 pp | USD69.41 +13.0% | 24 qtrs — |
| 95 | QUANTINNO CAPITAL MANAGEMENT LP | 40.2K +35.5K (+745.9%) | 3.15M +2.7M (+542.0%) | 0.11% +0.101 pp | 0.01% +0.005 pp | USD82.50 -4.9% | 3 qtrs — |
| 96 | PRUDENTIAL FINANCIAL INC | 36.5K -4.5K (-11.0%) | 2.86M -1.4M (-32.4%) | 0.10% -0.013 pp | 0.00% -0.002 pp | USD90.99 -13.8% | 38 qtrs — |
| 97 | CREATIVE PLANNING | 36.1K +26.4K (+272.7%) | 2.83M +1.8M (+182.9%) | 0.10% +0.075 pp | 0.00% +0.001 pp | USD87.33 -10.2% | 11 qtrs — |
| 98 | BANK OF MONTREAL /CAN/ | 35.1K +32.4K (+1,203.1%) | 2.75M +2.5M (+889.1%) | 0.10% +0.092 pp | 0.00% +0.001 pp | USD80.41 -2.5% | 38 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 145 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Health Care Equipment ETF XHE | 1.61% | 2.44M | 0.35% |
| 2 | Invesco S&P SmallCap Health Care ETF PSCH | 1.39% | 2.27M | 0.29% |
| 3 | iShares U.S. Medical Devices ETF IHI | 0.47% | 14.88M | 0.38% |
| 4 | Vanguard S&P Small-Cap 600 Value ETF VIOV | 0.36% | 6.93M | 0.10% |
| 5 | State Street SPDR S&P 600 Small Cap Value ETF SLYV | 0.35% | 16.85M | 0.15% |
| 6 | Royce Quant Small-Cap Quality Value ETF SQLV | 0.35% | 99.9K | 0.60% |
| 7 | iShares S&P Small-Cap 600 Value ETF IJS | 0.34% | 27.64M | 0.18% |
| 8 | iShares US Medical Devices UCITS ETF USD UMDV.AS | 0.33% | 568.0K | 0.25% |
| 9 | Global X - Aging Population ETF AGNG | 0.32% | 276.3K | 0.50% |
| 10 | WisdomTree U.S. SmallCap Fund EES | 0.30% | 2.17M | 0.38% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.73
Bullish
Buys
49
Sells
49
Shares acquired
159.4K
Shares disposed
92.0K
Cash buys
—
Cash sales
1.00
Net activity
+67,421
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Harris John A | Officer | M-Exempt | A | Common Stock | 3,837 | 0.00 | — | 10,499 | D | ↗ |
| 2026-03-24 | Carr Terence | Officer | F-InKind | D | Common Stock | 398 | 86.19 | 34.3K | 952 | D | ↗ |
| 2026-03-24 | Blackwood Lindsay K. | Officer | M-Exempt | D | Restricted Stock Units | 1,777 | 0.00 | — | 3,556 | D | ↗ |
| 2026-03-13 | Thomas Tommy P | Officer | S-Sale | D | Common Stock | 825 | 85.00 | 70.1K | 4,381 | D | ↗ |
| 2026-03-12 | Kapito Aaron | Director | A-Award | A | Common Stock | 410 | 0.00 | — | 1,371 | D | ↗ |
| 2026-03-12 | Flanagan James Francis | Director | A-Award | A | Common Stock | 410 | 0.00 | — | 410 | D | ↗ |
| 2026-02-24 | Khales Payman | Director / Officer | M-Exempt | A | Common Stock | 26,983 | 0.00 | — | 78,799 | D | ↗ |
| 2026-02-20 | Thor Kirk K | Officer | F-InKind | D | Common Stock | 2,198 | 84.85 | 186.5K | 34,982 | D | ↗ |
| 2026-02-20 | Thomas Tommy P | Officer | A-Award | A | Common Stock | 923 | 0.00 | — | 4,980 | D | ↗ |
| 2026-02-20 | Stephens Jim | Officer | F-InKind | D | Common Stock | 656 | 84.85 | 55.7K | 4,368 | D | ↗ |
| 2026-02-20 | Smith Diron | Officer | A-Award | A | Common Stock | 798 | 0.00 | — | 10,936 | D | ↗ |
| 2026-02-20 | Senn Andrew | Officer | A-Award | A | Common Stock | 2,340 | 0.00 | — | 13,880 | D | ↗ |
| 2026-02-20 | Khales Payman | Director / Officer | A-Award | A | Common Stock | 7,389 | 0.00 | — | 32,861 | D | ↗ |
| 2026-01-20 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 816 | 0.00 | — | 28,750 | D | ↗ |
| 2026-01-20 | Thomas Tommy P | Officer | M-Exempt | D | Restricted Stock Units | 337 | 0.00 | — | 0 | D | ↗ |
| 2026-01-20 | Smith Diron | Officer | F-InKind | D | Common Stock | 72 | 85.15 | 6.1K | 10,138 | D | ↗ |
| 2026-01-20 | Senn Andrew | Officer | M-Exempt | A | Common Stock | 2,224 | 0.00 | — | 12,625 | D | ↗ |
| 2026-01-20 | Khales Payman | Director / Officer | M-Exempt | A | Common Stock | 1,348 | 0.00 | — | 26,434 | D | ↗ |
| 2026-01-19 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 694 | 0.00 | — | 27,934 | D | ↗ |
| 2026-01-19 | Thomas Tommy P | Officer | F-InKind | D | Common Stock | 193 | 85.78 | 16.6K | 4,198 | D | ↗ |
| 2026-01-19 | Stephens Jim | Officer | F-InKind | D | Common Stock | 447 | 85.78 | 38.3K | 2,333 | D | ↗ |
| 2026-01-19 | Smith Diron | Officer | M-Exempt | D | Restricted Stock Units | 1,709 | 0.00 | — | 1,710 | D | ↗ |
| 2026-01-19 | Senn Andrew | Officer | M-Exempt | A | Common Stock | 363 | 0.00 | — | 10,401 | D | ↗ |
| 2026-01-19 | Khales Payman | Director / Officer | M-Exempt | D | Restricted Stock Units | 961 | 0.00 | — | 962 | D | ↗ |
| 2026-01-19 | Harris John A | Officer | M-Exempt | D | Restricted Stock Units | 636 | 0.00 | — | 636 | D | ↗ |
| 2026-01-17 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 551 | 0.00 | — | 27,240 | D | ↗ |
| 2026-01-17 | Thomas Tommy P | Officer | M-Exempt | A | Common Stock | 218 | 0.00 | — | 3,814 | D | ↗ |
| 2026-01-17 | Stephens Jim | Officer | M-Exempt | A | Common Stock | 748 | 0.00 | — | 2,780 | D | ↗ |
| 2026-01-17 | Smith Diron | Officer | M-Exempt | A | Common Stock | 1,359 | 0.00 | — | 9,057 | D | ↗ |
| 2026-01-17 | Senn Andrew | Officer | M-Exempt | D | Restricted Stock Units | 630 | 0.00 | — | 1,261 | D | ↗ |
| 2026-01-17 | Khales Payman | Director / Officer | M-Exempt | D | Restricted Stock Units | 1,260 | 0.00 | — | 2,522 | D | ↗ |
| 2026-01-17 | Harris John A | Officer | M-Exempt | A | Common Stock | 512 | 0.00 | — | 6,578 | D | ↗ |
| 2026-01-16 | Thor Kirk K | Officer | A-Award | A | Restricted Stock Units | 6,120 | 0.00 | — | 6,120 | D | ↗ |
| 2026-01-16 | Thomas Tommy P | Officer | A-Award | A | Restricted Stock Units | 1,049 | 0.00 | — | 1,049 | D | ↗ |
| 2026-01-16 | Stephens Jim | Officer | A-Award | A | Restricted Stock Units | 3,885 | 0.00 | — | 3,885 | D | ↗ |
| 2026-01-16 | Smith Diron | Officer | A-Award | A | Restricted Stock Units | 7,091 | 0.00 | — | 7,091 | D | ↗ |
| 2026-01-16 | Senn Andrew | Officer | A-Award | A | Restricted Stock Units | 3,497 | 0.00 | — | 3,497 | D | ↗ |
| 2026-01-16 | Khales Payman | Director / Officer | A-Award | A | Restricted Stock Units | 19,429 | 0.00 | — | 19,429 | D | ↗ |
| 2026-01-16 | Harris John A | Officer | A-Award | A | Restricted Stock Units | 5,440 | 0.00 | — | 5,440 | D | ↗ |
| 2026-01-16 | Carr Terence | Officer | A-Award | A | Restricted Stock Units | 1,554 | 0.00 | — | 1,554 | D | ↗ |
| 2026-01-16 | Blackwood Lindsay K. | Officer | A-Award | A | Restricted Stock Units | 2,720 | 0.00 | — | 2,720 | D | ↗ |
| 2026-01-02 | BAILEY PAMELA G | Director | F-InKind | D | Common Stock | 1,799 | 77.63 | 139.7K | 54,253 | D | ↗ |
| 2025-12-12 | MAXWELL MARTIN C | Director | M-Exempt | A | Common Stock | 2,883 | 48.43 | 139.6K | 25,053 | D | ↗ |
| 2025-11-12 | Harris John A | Officer | P-Purchase | A | Common Stock | 1,650 | 70.00 | 115.5K | 6,066 | D | ↗ |
| 2025-11-11 | Thomas Tommy P | Officer | S-Sale | D | Common Stock | 884 | 70.15 | 62.0K | 3,596 | D | ↗ |
| 2025-11-07 | Smith Diron | Officer | P-Purchase | A | Common Stock | 1,116 | 67.19 | 75.0K | 7,698 | D | ↗ |
| 2025-11-06 | Capps Cheryl C | Director | P-Purchase | A | Common Stock | 1,600 | 66.70 | 106.7K | 11,702 | D | ↗ |
| 2025-10-30 | Khales Payman | Director / Officer | P-Purchase | A | Common Stock | 3,127 | 64.94 | 203.1K | 22,865 | D | ↗ |
| 2025-10-24 | Khales Payman | Director / Officer | A-Award | A | Restricted Stock Units | 7,543 | 0.00 | — | 7,543 | D | ↗ |
| 2025-07-10 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 1,355 | 0.00 | — | 1,355 | D | ↗ |
| 2025-06-11 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 36,202 | 0.00 | — | 59,202 | D | ↗ |
| 2025-06-05 | MAXWELL MARTIN C | Director | S-Sale | D | Common Stock | 5,806 | 120.75 | 701.1K | 22,351 | D | ↗ |
| 2025-06-04 | Spence Donald J | Director | M-Exempt | A | Common Stock | 14,739 | 19.43 | 286.4K | 33,520 | D | ↗ |
| 2025-05-21 | Spence Donald J | Director | A-Award | A | Restricted Stock Units | 1,514 | 0.00 | — | 1,514 | D | ↗ |
| 2025-05-21 | PASSERINI FILIPPO | Director | A-Award | A | Common Stock | 1,514 | 0.00 | — | 29,147 | D | ↗ |
| 2025-05-21 | MAXWELL MARTIN C | Director | A-Award | A | Common Stock | 1,514 | 0.00 | — | 22,170 | D | ↗ |
| 2025-05-21 | Jeffers Alvin Tyrone | Director | A-Award | A | Restricted Stock Units | 1,514 | 0.00 | — | 1,514 | D | ↗ |
| 2025-05-21 | Hobby Jean M. | Director | A-Award | A | Common Stock | 1,514 | 0.00 | — | 3,794 | D | ↗ |
| 2025-05-21 | Hinrichs James F. | Director | A-Award | A | Restricted Stock Units | 1,514 | 0.00 | — | 1,514 | D | ↗ |
| 2025-05-21 | Capps Cheryl C | Director | A-Award | A | Common Stock | 1,514 | 0.00 | — | 10,102 | D | ↗ |
| 2025-05-21 | BAILEY PAMELA G | Director | A-Award | A | Restricted Stock Units | 2,018 | 0.00 | — | 2,018 | D | ↗ |
| 2025-05-21 | Antrum Sheila | Director | A-Award | A | Common Stock | 1,514 | 0.00 | — | 10,102 | D | ↗ |
| 2025-05-15 | Stephens Jim | Officer | M-Exempt | A | Common Stock | 491 | 0.00 | — | 1,394 | D | ↗ |
| 2025-05-08 | Smith Diron | Officer | M-Exempt | A | Common Stock | 2,063 | 0.00 | — | 7,288 | D | ↗ |
| 2025-05-05 | Dziedzic Joseph W | Director / Officer | G-Gift | D | Common Stock | 24,000 | 125.09 | 3.00M | 23,000 | D | ↗ |
| 2025-05-05 | Carr Terence | Officer | — | — | Restricted Stock Units | 4,052 | 0.00 | — | 0 | D | ↗ |
| 2025-05-01 | Dziedzic Joseph W | Director / Officer | S-Sale | D | Common Stock | 267,591 | 122.45 | 32.77M | 47,000 | D | ↗ |
| 2025-04-07 | ARORA SANJIV | Officer | A-Award | A | Restricted Stock Units | 2,213 | 0.00 | — | 2,213 | D | ↗ |
| 2025-03-24 | Blackwood Lindsay K. | Officer | A-Award | A | Restricted Stock Units | 3,413 | 0.00 | — | 3,413 | D | ↗ |
| 2025-03-11 | Dziedzic Joseph W | Director / Officer | M-Exempt | D | Performance Restricted Stock Units | 36,202 | 0.00 | — | 36,202 | D | ↗ |
| 2025-02-21 | Thor Kirk K | Officer | F-InKind | D | Common Stock | 2,322 | 129.87 | 301.6K | 26,689 | D | ↗ |
| 2025-02-21 | Thomas Tommy P | Officer | A-Award | A | Common Stock | 858 | 0.00 | — | 4,190 | D | ↗ |
| 2025-02-21 | Smith Diron | Officer | A-Award | A | Common Stock | 686 | 0.00 | — | 4,824 | D | ↗ |
| 2025-02-21 | Senn Andrew | Officer | A-Award | A | Common Stock | 2,088 | 0.00 | — | 10,633 | D | ↗ |
| 2025-02-21 | Marshall McAlister C II | Officer | A-Award | A | Common Stock | 3,074 | 0.00 | — | 8,672 | D | ↗ |
| 2025-02-21 | Khales Payman | Officer | F-InKind | D | Common Stock | 3,463 | 129.87 | 449.7K | 19,738 | D | ↗ |
| 2025-02-21 | Dziedzic Joseph W | Director / Officer | F-InKind | D | Common Stock | 34,618 | 129.87 | 4.50M | 291,784 | D | ↗ |
| 2025-02-21 | Carthy Margaret | Officer | A-Award | A | Common Stock | 1,928 | 0.00 | — | 7,677 | D | ↗ |
| 2025-01-21 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 690 | 0.00 | — | 21,689 | D | ↗ |
| 2025-01-21 | Thomas Tommy P | Officer | M-Exempt | D | Restricted Stock Units | 314 | 0.00 | — | 0 | D | ↗ |
| 2025-01-21 | Stephens Jim | Officer | F-InKind | D | Common Stock | 225 | 141.00 | 31.7K | 903 | D | ↗ |
| 2025-01-21 | Smith Diron | Officer | M-Exempt | D | Restricted Stock Units | 251 | 0.00 | — | 0 | D | ↗ |
| 2025-01-21 | Senn Andrew | Officer | M-Exempt | D | Restricted Stock Units | 348 | 0.00 | — | 0 | D | ↗ |
| 2025-01-21 | Marshall McAlister C II | Officer | M-Exempt | D | Restricted Stock Units | 722 | 0.00 | — | 0 | D | ↗ |
| 2025-01-21 | Khales Payman | Officer | F-InKind | D | Common Stock | 221 | 143.16 | 31.6K | 12,805 | D | ↗ |
| 2025-01-21 | Harris John A | Officer | F-InKind | D | Common Stock | 331 | 141.00 | 46.7K | 4,416 | D | ↗ |
| 2025-01-21 | Dziedzic Joseph W | Director / Officer | F-InKind | D | Common Stock | 3,015 | 143.16 | 431.6K | 238,430 | D | ↗ |
| 2025-01-21 | Carthy Margaret | Officer | M-Exempt | D | Restricted Stock Units | 352 | 0.00 | — | 0 | D | ↗ |
| 2025-01-20 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 816 | 0.00 | — | 20,999 | D | ↗ |
| 2025-01-20 | Thomas Tommy P | Officer | M-Exempt | D | Restricted Stock Units | 337 | 0.00 | — | 337 | D | ↗ |
| 2025-01-20 | Smith Diron | Officer | M-Exempt | A | Common Stock | 292 | 0.00 | — | 4,496 | D | ↗ |
| 2025-01-20 | Senn Andrew | Officer | M-Exempt | A | Common Stock | 2,224 | 0.00 | — | 7,245 | D | ↗ |
| 2025-01-20 | Marshall McAlister C II | Officer | M-Exempt | D | Restricted Stock Units | 719 | 0.00 | — | 719 | D | ↗ |
| 2025-01-20 | Khales Payman | Officer | M-Exempt | D | Restricted Stock Units | 1,347 | 0.00 | — | 1,348 | D | ↗ |
| 2025-01-20 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 8,235 | 0.00 | — | 238,323 | D | ↗ |
| 2025-01-20 | Carthy Margaret | Officer | M-Exempt | A | Common Stock | 539 | 0.00 | — | 6,103 | D | ↗ |
| 2025-01-19 | Thor Kirk K | Officer | M-Exempt | D | Restricted Stock Units | 694 | 0.00 | — | 1,389 | D | ↗ |
| 2025-01-19 | Thomas Tommy P | Officer | M-Exempt | D | Restricted Stock Units | 240 | 0.00 | — | 481 | D | ↗ |
| 2025-01-19 | Stephens Jim | Officer | M-Exempt | A | Common Stock | 758 | 0.00 | — | 1,128 | D | ↗ |
| 2025-01-19 | Smith Diron | Officer | M-Exempt | D | Restricted Stock Units | 1,709 | 0.00 | — | 3,419 | D | ↗ |
| 2025-01-19 | Senn Andrew | Officer | M-Exempt | D | Restricted Stock Units | 363 | 0.00 | — | 726 | D | ↗ |
| 2025-01-19 | Marshall McAlister C II | Officer | M-Exempt | A | Common Stock | 641 | 0.00 | — | 2,033 | D | ↗ |
| 2025-01-19 | Khales Payman | Officer | M-Exempt | A | Common Stock | 961 | 0.00 | — | 11,392 | D | ↗ |
| 2025-01-19 | Harris John A | Officer | M-Exempt | D | Restricted Stock Units | 635 | 0.00 | — | 1,272 | D | ↗ |
| 2025-01-19 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 5,876 | 0.00 | — | 230,088 | D | ↗ |
| 2025-01-19 | Carthy Margaret | Officer | M-Exempt | A | Common Stock | 462 | 0.00 | — | 5,564 | D | ↗ |
| 2025-01-17 | Thor Kirk K | Officer | A-Award | A | Restricted Stock Units | 1,654 | 0.00 | — | 1,654 | D | ↗ |
| 2025-01-17 | Thomas Tommy P | Officer | A-Award | A | Restricted Stock Units | 656 | 0.00 | — | 656 | D | ↗ |
| 2025-01-17 | Stephens Jim | Officer | A-Award | A | Restricted Stock Units | 2,245 | 0.00 | — | 2,245 | D | ↗ |
| 2025-01-17 | Smith Diron | Officer | A-Award | A | Restricted Stock Units | 4,078 | 0.00 | — | 4,078 | D | ↗ |
| 2025-01-17 | Senn Andrew | Officer | A-Award | A | Restricted Stock Units | 1,891 | 0.00 | — | 1,891 | D | ↗ |
| 2025-01-17 | Khales Payman | Officer | A-Award | A | Restricted Stock Units | 3,782 | 0.00 | — | 3,782 | D | ↗ |
| 2025-01-17 | Harris John A | Officer | A-Award | A | Restricted Stock Units | 1,536 | 0.00 | — | 1,536 | D | ↗ |
| 2025-01-17 | Dziedzic Joseph W | Director / Officer | A-Award | A | Restricted Stock Units | 14,184 | 0.00 | — | 14,184 | D | ↗ |
| 2025-01-17 | Carthy Margaret | Officer | A-Award | A | Restricted Stock Units | 1,418 | 0.00 | — | 1,418 | D | ↗ |
| 2025-01-03 | Harris John A | Officer | M-Exempt | A | Common Stock | 5,396 | 0.00 | — | 6,918 | D | ↗ |
| 2025-01-02 | Dziedzic Joseph W | Director / Officer | M-Exempt | D | Stock Options | 2,877 | 45.39 | 130.6K | 0 | D | ↗ |
| 2025-01-02 | BAILEY PAMELA G | Director | M-Exempt | A | Common Stock | 2,877 | 45.39 | 130.6K | 54,143 | D | ↗ |
| 2024-09-01 | Smith Diron | Officer | M-Exempt | A | Common Stock | 168 | 0.00 | — | 2,536 | — | ↗ |
| 2024-07-31 | MAXWELL MARTIN C | Director | S-Sale | D | Common Stock | 4,700 | 118.88 | 558.7K | 20,656 | — | ↗ |
| 2024-07-31 | Hobby Jean M. | Director | M-Exempt | A | Common Stock | 1,410 | 49.90 | 70.4K | 9,600 | — | ↗ |
| 2024-07-30 | Harris John A | Officer | S-Sale | D | Common Stock | 3,400 | 123.80 | 420.9K | 1,522 | — | ↗ |
| 2024-07-11 | Harris John A | Officer | A-Award | A | Restricted Stock Units | 3,837 | 0.00 | — | 3,837 | — | ↗ |
| 2024-06-12 | SUMMERS WILLIAM B JR | Director | G-Gift | D | Common Stock | 1,000 | 0.00 | — | 44,410 | — | ↗ |
| 2024-06-04 | Harris John A | Officer | S-Sale | D | Common Stock | 1,521 | 120.44 | 183.2K | 4,922 | — | ↗ |
| 2024-05-31 | Harris John A | Officer | M-Exempt | A | Common Stock | 11,013 | 0.00 | — | 12,170 | — | ↗ |
| 2024-05-24 | Hinrichs James F. | Director | S-Sale | D | Common Stock | 9,603 | 122.44 | 1.18M | 7,424 | — | ↗ |
| 2024-05-22 | Spence Donald J | Director | A-Award | A | Restricted Stock Units | 1,480 | 0.00 | — | 1,480 | — | ↗ |
| 2024-05-22 | SUMMERS WILLIAM B JR | Director | A-Award | A | Restricted Stock Units | 1,480 | 0.00 | — | 1,480 | — | ↗ |
| 2024-05-22 | PASSERINI FILIPPO | Director | A-Award | A | Common Stock | 1,480 | 0.00 | — | 27,633 | — | ↗ |
| 2024-05-22 | MAXWELL MARTIN C | Director | A-Award | A | Common Stock | 1,480 | 0.00 | — | 25,356 | — | ↗ |
| 2024-05-22 | Jeffers Alvin Tyrone | Director | A-Award | A | Restricted Stock Units | 1,480 | 0.00 | — | 1,480 | — | ↗ |
| 2024-05-22 | Hobby Jean M. | Director | A-Award | A | Restricted Stock Units | 1,480 | 0.00 | — | 1,480 | — | ↗ |
| 2024-05-22 | Hinrichs James F. | Director | A-Award | A | Restricted Stock Units | 1,480 | 0.00 | — | 1,480 | — | ↗ |
| 2024-05-22 | Capps Cheryl C | Director | A-Award | A | Common Stock | 1,480 | 0.00 | — | 8,588 | — | ↗ |
| 2024-05-22 | BAILEY PAMELA G | Director | A-Award | A | Restricted Stock Units | 1,974 | 0.00 | — | 1,974 | — | ↗ |
| 2024-05-22 | Antrum Sheila | Director | A-Award | A | Common Stock | 1,480 | 0.00 | — | 8,588 | — | ↗ |
| 2024-05-15 | Stephens Jim | Officer | M-Exempt | D | Restricted Stock Units | 490 | 0.00 | — | 982 | — | ↗ |
| 2024-05-10 | Khales Payman | Officer | S-Sale | D | Common Stock | 8,712 | 113.84 | 991.7K | 10,431 | — | ↗ |
| 2024-05-08 | Smith Diron | Officer | M-Exempt | D | Restricted Stock Units | 2,062 | 0.00 | — | 4,126 | — | ↗ |
| 2024-05-07 | Senn Andrew | Officer | S-Sale | D | Common Stock | 300 | 114.04 | 34.2K | 4,658 | — | ↗ |
| 2024-05-07 | Harris John A | Officer | S-Sale | D | Common Stock | 312 | 113.00 | 35.3K | 1,157 | — | ↗ |
| 2024-04-30 | Thomas Tommy P | Officer | S-Sale | D | Common Stock | 1,500 | 114.00 | 171.0K | 2,813 | — | ↗ |
| 2024-02-22 | Thor Kirk K | Officer | F-InKind | D | Common Stock | 2,121 | 100.18 | 212.5K | 19,489 | — | ↗ |
| 2024-02-22 | Thomas Tommy P | Officer | F-InKind | D | Common Stock | 496 | 100.18 | 49.7K | 4,313 | — | ↗ |
| 2024-02-22 | Senn Andrew | Officer | F-InKind | D | Common Stock | 444 | 100.18 | 44.5K | 9,658 | — | ↗ |
| 2024-02-22 | Khales Payman | Officer | A-Award | A | Common Stock | 11,592 | 0.00 | — | 22,720 | — | ↗ |
| 2024-02-22 | Harris John A | Officer | F-InKind | D | Common Stock | 1,255 | 100.18 | 125.7K | 1,469 | — | ↗ |
| 2024-02-22 | Dziedzic Joseph W | Director / Officer | F-InKind | D | Common Stock | 30,821 | 100.18 | 3.09M | 222,319 | — | ↗ |
| 2024-02-22 | Carthy Margaret | Officer | F-InKind | D | Common Stock | 853 | 100.18 | 85.5K | 5,102 | — | ↗ |
| 2024-01-22 | Thor Kirk K | Officer | M-Exempt | A | Common Stock | 744 | 0.00 | — | 13,933 | — | ↗ |
| 2024-01-22 | Thomas Tommy P | Officer | F-InKind | D | Common Stock | 272 | 103.99 | 28.3K | 3,610 | — | ↗ |
| 2024-01-22 | Smith Diron | Officer | F-InKind | D | Common Stock | 162 | 103.99 | 16.8K | 809 | — | ↗ |
| 2024-01-22 | Senn Andrew | Officer | F-InKind | D | Common Stock | 864 | 103.99 | 89.8K | 8,774 | — | ↗ |
| 2024-01-22 | Marshall McAlister C II | Officer | F-InKind | D | Common Stock | 511 | 103.99 | 53.1K | 1,392 | — | ↗ |
| 2024-01-22 | Khales Payman | Officer | M-Exempt | A | Common Stock | 1,039 | 0.00 | — | 12,003 | — | ↗ |
| 2024-01-22 | Harris John A | Officer | M-Exempt | A | Common Stock | 650 | 0.00 | — | 650 | — | ↗ |
| 2024-01-22 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 7,021 | 0.00 | — | 182,452 | — | ↗ |
| 2024-01-22 | Carthy Margaret | Officer | M-Exempt | D | Restricted Stock Units | 442 | 0.00 | — | 0 | — | ↗ |
| 2024-01-21 | Thor Kirk K | Officer | M-Exempt | D | Restricted Stock Units | 689 | 0.00 | — | 690 | — | ↗ |
| 2024-01-21 | Thomas Tommy P | Officer | M-Exempt | A | Common Stock | 313 | 0.00 | — | 3,518 | — | ↗ |
| 2024-01-21 | Smith Diron | Officer | M-Exempt | A | Common Stock | 251 | 0.00 | — | 971 | — | ↗ |
| 2024-01-21 | Senn Andrew | Officer | M-Exempt | D | Restricted Stock Units | 348 | 0.00 | — | 348 | — | ↗ |
| 2024-01-21 | Marshall McAlister C II | Officer | M-Exempt | A | Common Stock | 721 | 0.00 | — | 1,903 | — | ↗ |
| 2024-01-21 | Khales Payman | Officer | M-Exempt | D | Restricted Stock Units | 905 | 0.00 | — | 906 | — | ↗ |
| 2024-01-21 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 7,662 | 0.00 | — | 175,431 | — | ↗ |
| 2024-01-21 | Carthy Margaret | Officer | M-Exempt | A | Common Stock | 352 | 0.00 | — | 4,568 | — | ↗ |
| 2024-01-20 | Thor Kirk K | Officer | M-Exempt | D | Restricted Stock Units | 816 | 0.00 | — | 1,632 | — | ↗ |
| 2024-01-20 | Thomas Tommy P | Officer | M-Exempt | D | Restricted Stock Units | 336 | 0.00 | — | 674 | — | ↗ |
| 2024-01-20 | Smith Diron | Officer | M-Exempt | A | Common Stock | 291 | 0.00 | — | 720 | — | ↗ |
| 2024-01-20 | Senn Andrew | Officer | M-Exempt | A | Common Stock | 2,222 | 0.00 | — | 8,900 | — | ↗ |
| 2024-01-20 | Marshall McAlister C II | Officer | M-Exempt | D | Restricted Stock Units | 718 | 0.00 | — | 1,438 | — | ↗ |
| 2024-01-20 | Khales Payman | Officer | M-Exempt | D | Restricted Stock Units | 1,347 | 0.00 | — | 2,695 | — | ↗ |
| 2024-01-20 | Dziedzic Joseph W | Director / Officer | M-Exempt | D | Restricted Stock Units | 8,234 | 0.00 | — | 16,470 | — | ↗ |
| 2024-01-20 | Carthy Margaret | Officer | M-Exempt | A | Common Stock | 539 | 0.00 | — | 4,216 | — | ↗ |
| 2024-01-19 | Thor Kirk K | Officer | A-Award | A | Restricted Stock Units | 2,083 | 0.00 | — | 2,083 | — | ↗ |
| 2024-01-19 | Thomas Tommy P | Officer | A-Award | A | Restricted Stock Units | 721 | 0.00 | — | 721 | — | ↗ |
| 2024-01-19 | Stephens Jim | Officer | A-Award | A | Restricted Stock Units | 2,275 | 0.00 | — | 2,275 | — | ↗ |
| 2024-01-19 | Smith Diron | Officer | A-Award | A | Restricted Stock Units | 5,128 | 0.00 | — | 5,128 | — | ↗ |
| 2024-01-19 | Senn Andrew | Officer | A-Award | A | Restricted Stock Units | 3,846 | 0.00 | — | 3,846 | — | ↗ |
| 2024-01-19 | Marshall McAlister C II | Officer | A-Award | A | Restricted Stock Units | 1,923 | 0.00 | — | 1,923 | — | ↗ |
| 2024-01-19 | Khales Payman | Officer | A-Award | A | Restricted Stock Units | 2,884 | 0.00 | — | 2,884 | — | ↗ |
| 2024-01-19 | Harris John A | Officer | A-Award | A | Restricted Stock Units | 1,907 | 0.00 | — | 1,907 | — | ↗ |
| 2024-01-19 | Dziedzic Joseph W | Director / Officer | A-Award | A | Restricted Stock Units | 17,629 | 0.00 | — | 17,629 | — | ↗ |
| 2024-01-19 | Carthy Margaret | Officer | A-Award | A | Restricted Stock Units | 1,387 | 0.00 | — | 1,387 | — | ↗ |
| 2024-01-02 | Dziedzic Joseph W | Director / Officer | M-Exempt | A | Common Stock | 1,722 | 40.86 | 70.4K | 159,535 | — | ↗ |
| 2024-01-02 | BAILEY PAMELA G | Director | M-Exempt | D | Stock Options | 1,722 | 40.86 | 70.4K | 0 | — | ↗ |
| 2023-09-11 | Spence Donald J | Director | M-Exempt | A | Common Stock | 1,206 | 19.43 | 23.4K | 19,987 | — | ↗ |
| 2023-09-01 | Smith Diron | Officer | M-Exempt | A | Common Stock | 168 | 0.00 | — | 470 | — | ↗ |
| 2023-06-09 | Hobby Jean M. | Director | S-Sale | D | Common Stock | 3,625 | 83.85 | 304.0K | 9,126 | — | ↗ |
| 2023-05-24 | Stephens Jim | Officer | — | D | Restricted Stock Units | 1,472 | 0.00 | — | 0 | — | ↗ |
| 2023-05-24 | Spence Donald J | Director | A-Award | A | Restricted Stock Units | 2,246 | 0.00 | — | 2,246 | — | ↗ |
| 2023-05-24 | SUMMERS WILLIAM B JR | Director | A-Award | A | Restricted Stock Units | 2,246 | 0.00 | — | 2,246 | — | ↗ |
| 2023-05-24 | PASSERINI FILIPPO | Director | A-Award | A | Common Stock | 2,246 | 0.00 | — | 26,153 | — | ↗ |
| 2023-05-24 | MAXWELL MARTIN C | Director | A-Award | A | Common Stock | 2,246 | 0.00 | — | 23,876 | — | ↗ |
| 2023-05-24 | Jeffers Alvin Tyrone | Director | A-Award | A | Restricted Stock Units | 2,246 | 0.00 | — | 2,246 | — | ↗ |
| 2023-05-24 | Hobby Jean M. | Director | A-Award | A | Common Stock | 2,246 | 0.00 | — | 12,751 | — | ↗ |
| 2023-05-24 | Hinrichs James F. | Director | A-Award | A | Restricted Stock Units | 2,246 | 0.00 | — | 2,246 | — | ↗ |
| 2023-05-24 | Capps Cheryl C | Director | A-Award | A | Common Stock | 2,246 | 0.00 | — | 7,108 | — | ↗ |
| 2023-05-24 | BAILEY PAMELA G | Director | A-Award | A | Restricted Stock Units | 2,995 | 0.00 | — | 2,995 | — | ↗ |
Executive team
Top executives
EBIT / Employee
19.0K
Shares Outstanding
34.41M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph W. Dziedzic Former President and CEO | 1.24M | — | 6.00M | — | 1.32M | 112.6K | 8.67M | 69.19% | ↗ |
| 2 | 2025 | Payman Khales President and CEO | 637.0K | — | 2.15M | — | 363.6K | 61.3K | 3.21M | 66.94% | ↗ |
| 3 | 2025 | Diron Smith Executive Vice President and Chief Financial Officer | 499.1K | — | 1.72M | — | 321.0K | 24.0K | 2.57M | 67.14% | ↗ |
| 4 | 2025 | Andrew Senn President, Cardio & Vascular | 434.1K | 250.0K | 800.0K | — | 195.2K | 28.6K | 1.71M | 46.84% | ↗ |
| 5 | 2025 | Jim Stephens President, Cardiac Rhythm Management & Neuromodulation | 504.4K | — | 949.9K | — | 227.9K | 10.5K | 1.69M | 56.12% | ↗ |
| 6 | 2025 | Lindsay K. Blackwood Senior Vice President, General Counsel and Corporate Secretary | 365.4K | 50.0K | 1.02M | — | 203.7K | — | 1.64M | 62.34% | ↗ |
| 7 | 2024 | Joseph W. Dziedzic President and Chief Executive Officer | 1.24M | — | 5.50M | — | 1.81M | 128.9K | 8.68M | 63.40% | ↗ |
| 8 | 2024 | Joseph W. Dziedzic Former President and CEO | 1.24M | — | 5.50M | — | 1.81M | 128.9K | 8.68M | 63.40% | ↗ |
| 9 | 2024 | Diron Smith Executive Vice President and Chief Financial Officer | 440.0K | — | 1.60M | — | 410.7K | 22.1K | 2.47M | 64.70% | ↗ |
| 10 | 2024 | Payman Khales President, Cardio & Vascular | 550.0K | — | 899.9K | — | 474.8K | 52.1K | 1.98M | 45.52% | ↗ |
| 11 | 2024 | Payman Khales President and CEO | 550.0K | — | 899.9K | — | 447.3K | 10.5K | 1.91M | 47.17% | ↗ |
| 12 | 2024 | John Harris Executive Vice President, Global Operations and Manufacturing Strategy | 419.4K | — | 1.04M | — | 313.8K | 89.5K | 1.87M | 55.95% | ↗ |
| 13 | 2024 | Jim Stephens President, Cardiac Rhythm Management & Neuromodulation | 461.8K | — | 709.9K | — | 411.6K | 17.3K | 1.60M | 44.35% | ↗ |
| 14 | 2023 | Joseph W. Dziedzic Former President and CEO | 1.23M | — | 5.50M | — | 1.91M | 97.7K | 8.74M | 62.94% | ↗ |
| 15 | 2023 | Joseph W. Dziedzic President and Chief Executive Officer | 1.23M | — | 5.50M | — | 1.91M | 97.7K | 8.74M | 62.94% | ↗ |
| 16 | 2023 | Payman Khales President and CEO | 528.8K | — | 2.90M | — | 572.0K | 35.8K | 4.04M | 71.84% | ↗ |
| 17 | 2023 | Payman Khales President, Cardio & Vascular | 528.8K | — | 2.90M | — | 572.0K | 35.8K | 4.04M | 71.84% | ↗ |
| 18 | 2023 | Jason K. Garland Former Executive Vice President and Chief Financial Officer | 195.4K | — | 1.52M | — | — | 606.2K | 2.33M | 65.55% | ↗ |
| 19 | 2023 | Jennifer M. Bolt Former Executive Vice President, Global Operations and ESG | 399.4K | — | 575.0K | — | — | 526.6K | 1.50M | 38.31% | ↗ |
| 20 | 2023 | Kirk Thor Executive Vice President and Chief Human Resources Officer | 396.8K | — | 545.0K | — | 365.4K | 29.4K | 1.34M | 40.77% | ↗ |
| 21 | 2023 | McAlister Marshall Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary | 430.5K | — | 479.9K | — | 396.4K | 28.0K | 1.33M | 35.96% | ↗ |
| 22 | 2023 | Diron Smith Vice President and Interim Chief Financial Officer | 345.9K | — | 630.0K | — | 289.2K | 16.2K | 1.28M | 49.17% | ↗ |
| 23 | 2023 | Diron Smith Executive Vice President and Chief Financial Officer | 345.9K | — | 630.0K | — | 289.2K | 16.2K | 1.28M | 49.17% | ↗ |
| 24 | 2022 | Joseph W. Dziedzic President and Chief Executive Officer | 1.16M | — | 9.50M | — | 742.8K | 94.8K | 11.50M | 82.64% | ↗ |
| 25 | 2022 | Jason K. Garland Executive Vice President and Chief Financial Officer | 541.3K | — | 2.36M | — | 221.0K | 33.2K | 3.16M | 74.83% | ↗ |
| 26 | 2022 | Jason K. Garland Former Executive Vice President and Chief Financial Officer | 541.3K | — | 2.36M | — | 221.0K | 33.2K | 3.16M | 74.83% | ↗ |
| 27 | 2022 | Payman Khales President, Cardio & Vascular | 443.9K | — | 1.65M | — | 176.1K | 32.9K | 2.30M | 71.65% | ↗ |
| 28 | 2022 | Carter Houghton President, Electrochem and Power Solutions | 381.2K | 385.0K | 500.0K | — | 131.3K | 21.1K | 1.42M | 35.25% | ↗ |
| 29 | 2022 | Jennifer M. Bolt Former Executive Vice President, Global Operations and ESG | 441.5K | — | 559.9K | — | 125.9K | 31.2K | 1.16M | 48.33% | ↗ |
| 30 | 2022 | Jennifer M. Bolt Executive Vice President, Global Operations and ESG | 441.5K | — | 559.9K | — | 125.9K | 31.2K | 1.16M | 48.33% | ↗ |
| 31 | 2021 | Joseph W. Dziedzic President and Chief Executive Officer | 994.7K | — | 5.00M | — | 855.0K | 72.4K | 6.92M | 72.23% | ↗ |
| 32 | 2021 | Jason K. Garland Former Executive Vice President and Chief Financial Officer | 505.0K | — | 1.09M | — | 256.5K | 30.8K | 1.88M | 57.91% | ↗ |
| 33 | 2021 | Jason K. Garland Executive Vice President and Chief Financial Officer | 505.0K | — | 1.09M | — | 256.5K | 30.8K | 1.88M | 57.91% | ↗ |
| 34 | 2021 | Payman Khales President, Cardio & Vascular | 418.7K | — | 740.0K | — | 193.2K | 33.3K | 1.39M | 53.42% | ↗ |
| 35 | 2021 | Jennifer M. Bolt Former Executive Vice President, Global Operations and ESG | 407.9K | — | 714.9K | — | 180.4K | 27.6K | 1.33M | 53.72% | ↗ |
| 36 | 2021 | Jennifer M. Bolt Senior Vice President, Global Operations and ESG | 407.9K | — | 714.9K | — | 180.4K | 27.6K | 1.33M | 53.72% | ↗ |
| 37 | 2021 | Jennifer M. Bolt Executive Vice President, Global Operations and ESG | 407.9K | — | 714.9K | — | 180.4K | 27.6K | 1.33M | 53.72% | ↗ |
| 38 | 2021 | Joel Becker President, Cardiac Rhythm Management & Neuromodulation | 418.7K | — | 590.0K | — | 186.8K | 31.8K | 1.23M | 48.08% | ↗ |
| 39 | 2020 | Joseph W. Dziedzic President and Chief Executive Officer | 1.00M | — | 4.00M | — | 880.2K | 43.5K | 5.92M | 67.52% | ↗ |
| 40 | 2020 | Jason K. Garland Executive Vice President and Chief Financial Officer | 498.8K | — | 925.9K | — | 259.4K | 18.5K | 1.70M | 54.38% | ↗ |
| 41 | 2020 | Payman Khales President, Cardio & Vascular | 410.8K | — | 493.9K | — | 204.6K | 26.1K | 1.14M | 43.50% | ↗ |
| 42 | 2020 | Joel Becker President, Cardiac Rhythm Management & Neuromodulation | 423.3K | — | 493.9K | — | 155.5K | 11.7K | 1.08M | 45.55% | ↗ |
| 43 | 2020 | Jennifer M. Bolt Senior Vice President, Global Operations and ESG | 402.9K | — | 399.9K | — | 186.0K | 26.9K | 1.02M | 39.37% | ↗ |
| 44 | 2020 | Jennifer M. Bolt Executive Vice President, Global Operations and ESG | 402.9K | — | 399.9K | — | 186.0K | 26.9K | 1.02M | 39.37% | ↗ |
| 45 | 2019 | Joseph W. Dziedzic President & Chief Executive Officer | 913.4K | — | 3.52M | — | 1.24M | 70.9K | 5.74M | 61.25% | ↗ |
| 46 | 2019 | Joseph W. Dziedzic President and Chief Executive Officer | 913.4K | — | 3.52M | — | 1.24M | 70.9K | 5.74M | 61.25% | ↗ |
| 47 | 2019 | Jason K. Garland Executive Vice President and Chief Financial Officer | 445.0K | — | 799.9K | — | 357.5K | 277.6K | 1.88M | 42.55% | ↗ |
| 48 | 2019 | Jason K. Garland Executive Vice President & Chief Financial Officer | 445.0K | — | 799.9K | — | 357.5K | 277.6K | 1.88M | 42.55% | ↗ |
| 49 | 2019 | Carter Houghton President, Electrochem and Power Solutions | 215.4K | — | 889.9K | — | 120.8K | 132.4K | 1.36M | 65.51% | ↗ |
| 50 | 2019 | Payman Khales President, Cardio & Vascular | 340.6K | — | 450.0K | — | 273.7K | 27.3K | 1.09M | 41.22% | ↗ |
| 51 | 2019 | Jennifer M. Bolt Senior Vice President, Global Operations and ESG | 337.5K | 50.1K | 374.7K | — | 274.6K | 28.6K | 1.07M | 35.17% | ↗ |
| 52 | 2019 | Jennifer M. Bolt Senior Vice President, Global Operations | 337.5K | 50.1K | 374.7K | — | 274.6K | 28.6K | 1.07M | 35.17% | ↗ |
| 53 | 2018 | Joseph W. Dziedzic President & Chief Executive Officer | 869.1K | — | 3.31M | — | 1.11M | 89.8K | 5.38M | 61.57% | ↗ |
| 54 | 2018 | Joseph W. Dziedzic President and Chief Executive Officer | 869.1K | — | 3.31M | — | 1.11M | 89.8K | 5.38M | 61.57% | ↗ |
| 55 | 2018 | Declan Smyth President, Advanced Surgical & Orthopedics | 340.4K | 895.0K | 499.9K | — | — | 25.0K | 1.76M | 28.40% | ↗ |
| 56 | 2018 | Gary J. Haire Former Executive Vice President & Chief Financial Officer | 176.4K | — | 699.9K | — | — | 865.4K | 1.74M | 40.19% | ↗ |
| 57 | 2018 | Kirk Thor Executive Vice President & Chief Human Resources Officer | 332.2K | 53.0K | 559.9K | — | 289.5K | 15.3K | 1.25M | 44.80% | ↗ |
| 58 | 2018 | Jeremy Friedman Former Executive Vice President & Interim Chief Financial Officer | 550.0K | — | — | — | 539.9K | 72.5K | 1.16M | 0.00% | ↗ |
| 59 | 2018 | Antonio Gonzalez President, CRM & | 318.8K | — | 499.9K | — | 228.9K | 37.8K | 1.09M | 46.06% | ↗ |
| 60 | 2018 | Neuromodulation Joseph Flanagan Executive Vice President, Quality and Regulatory Affairs | 309.3K | — | 309.9K | — | 248.8K | 33.7K | 901.7K | 34.37% | ↗ |
| 61 | 2018 | Jason K. Garland Executive Vice President and Chief Financial Officer | 99.2K | 50.0K | 551.8K | — | 64.5K | 30.7K | 796.3K | 69.30% | ↗ |
| 62 | 2018 | Jason K. Garland Executive Vice President & Chief Financial Officer | 99.2K | 50.0K | 551.8K | — | 64.5K | 30.7K | 796.3K | 69.30% | ↗ |
| 63 | 2017 | Thomas J. Hook Former President & Chief Executive Officer | 329.2K | — | 3.86M | — | — | 1.76M | 5.95M | 64.85% | ↗ |
| 64 | 2017 | Joseph W. Dziedzic President & Chief Executive Officer | 571.1K | 166.2K | 3.09M | 1.01M | — | 57.2K | 4.89M | 83.75% | ↗ |
| 65 | 2017 | Jeremy Friedman Executive Vice President & Chief Operating Officer | 539.4K | — | 2.54M | — | — | 77.3K | 3.16M | 80.46% | ↗ |
| 66 | 2017 | Jeremy Friedman Former Executive Vice President & Interim Chief Financial Officer | 539.4K | — | 2.54M | — | — | 77.3K | 3.16M | 80.46% | ↗ |
| 67 | 2017 | Kristin Trecker Former EVP & Chief Human Resources Officer | 133.3K | — | 530.4K | — | — | 448.6K | 1.11M | 47.69% | ↗ |
| 68 | 2017 | Surgical & Orthopedics John Harris Former interim President, Cardio & Vascular | 395.5K | 45.0K | 559.3K | — | — | 80.6K | 1.08M | 51.76% | ↗ |
| 69 | 2017 | Gary J. Haire Executive Vice President & Chief Financial Officer | 274.6K | — | 482.0K | 300.0K | — | 11.2K | 1.07M | 73.23% | ↗ |
| 70 | 2017 | Gary J. Haire Former Executive Vice President & Chief Financial Officer | 274.6K | — | 482.0K | 300.0K | — | 11.2K | 1.07M | 73.23% | ↗ |
| 71 | 2017 | Declan Smyth President, Advanced Surgical & Orthopedics | 333.5K | — | 648.2K | — | — | 15.8K | 997.5K | 64.98% | ↗ |
| 72 | 2017 | Declan Smyth President, Advanced | 333.5K | — | 648.2K | — | — | 15.8K | 997.5K | 64.98% | ↗ |
| 73 | 2017 | Michael Dinkins Former EVP & Chief Financial Officer | 79.8K | — | — | — | — | 455.8K | 535.6K | 0.00% | ↗ |
| 74 | 2017 | Thomas J. Mazza Former interim Chief Financial Officer | 275.2K | 30.0K | 139.5K | — | — | 10.5K | 455.2K | 30.64% | ↗ |
| 75 | 2016 | Thomas J. Hook Former President & Chief Executive Officer | 800.0K | — | 1.57M | 860.2K | — | 192.5K | 3.42M | 71.00% | ↗ |
| 76 | 2016 | Thomas J. Hook President & Chief Executive Officer | 800.0K | — | 1.57M | 860.2K | — | 192.5K | 3.42M | 71.00% | ↗ |
| 77 | 2016 | Jeremy Friedman Chief Operations Officer | 491.4K | 1.59M | — | 301.5K | — | 55.6K | 2.44M | 12.35% | ↗ |
| 78 | 2016 | Jeremy Friedman Executive Vice President & Chief Operating Officer | 491.4K | 1.59M | — | 301.5K | — | 55.6K | 2.44M | 12.35% | ↗ |
| 79 | 2016 | Jeremy Friedman Former Executive Vice President & Interim Chief Financial Officer | 491.4K | 1.59M | — | 301.5K | — | 55.6K | 2.44M | 12.35% | ↗ |
| 80 | 2016 | Declan Smyth President, Advanced | 338.4K | 130.0K | 684.7K | 161.5K | — | 10.5K | 1.33M | 63.86% | ↗ |
| 81 | 2016 | Declan Smyth President, Advanced Surgical and Orthopedics | 338.4K | 130.0K | 684.7K | 161.5K | — | 10.5K | 1.33M | 63.86% | ↗ |
| 82 | 2016 | Declan Smyth President, Advanced Surgical & Orthopedics | 338.4K | 130.0K | 684.7K | 161.5K | — | 10.5K | 1.33M | 63.86% | ↗ |
| 83 | 2016 | Michael Dinkins Executive Vice President & Chief Financial Officer | 415.0K | — | 435.6K | 238.7K | — | 34.9K | 1.12M | 59.98% | ↗ |
| 84 | 2016 | Michael Dinkins Former EVP & Chief Financial Officer | 415.0K | — | 435.6K | 238.7K | — | 34.9K | 1.12M | 59.98% | ↗ |
| 85 | 2016 | Mauricio Arellano Executive Vice President, Global Operations | 259.6K | — | 444.9K | 243.8K | — | 131.9K | 1.08M | 63.75% | ↗ |
| 86 | 2016 | Kristin Trecker Former EVP & Chief Human Resources Officer | 315.0K | — | 251.5K | 137.8K | — | 170.7K | 875.1K | 44.49% | ↗ |
| 87 | 2016 | Kristin Trecker Executive Vice President & Chief Human Resources Officer | 315.0K | — | 251.5K | 137.8K | — | 170.7K | 875.1K | 44.49% | ↗ |
| 88 | 2015 | Thomas J. Hook President & Chief Executive Officer | 719.2K | — | 1.53M | 752.5K | — | 140.5K | 3.14M | 72.61% | ↗ |
| 89 | 2015 | Thomas J. Hook Former President & Chief Executive Officer | 719.2K | — | 1.53M | 752.5K | — | 140.5K | 3.14M | 72.61% | ↗ |
| 90 | 2015 | Michael Dinkins Former EVP & Chief Financial Officer | 383.7K | — | 494.9K | 243.9K | — | 38.4K | 1.16M | 63.64% | ↗ |
| 91 | 2015 | Michael Dinkins Executive Vice President & Chief Financial Officer | 383.7K | — | 494.9K | 243.9K | — | 38.4K | 1.16M | 63.64% | ↗ |
| 92 | 2015 | Mauricio Arellano Executive Vice President, Global Operations | 350.4K | — | 447.1K | 220.4K | — | 27.0K | 1.04M | 63.88% | ↗ |
| 93 | 2015 | Andrew P. Holman President, Corporate Development | 315.0K | — | 415.4K | 204.8K | — | 34.7K | 969.8K | 63.94% | ↗ |
| 94 | 2015 | George Cintra Executive Vice President & Chief Technology Officer | 250.0K | — | 291.6K | 143.7K | — | 39.9K | 725.3K | 60.03% | ↗ |
| 95 | 2015 | Timothy G. McEvoy Senior Vice President, General Counsel & Secretary | 280.8K | — | 170.4K | 84.0K | — | 107.5K | 642.7K | 39.58% | ↗ |
| 96 | 2014 | Thomas J. Hook President Chief Executive Officer | 700.0K | — | 1.61M | 752.5K | 514.1K | 130.5K | 3.71M | 63.76% | ↗ |
| 97 | 2014 | Thomas J. Hook President & Chief Executive Officer | 700.0K | — | 1.61M | 752.5K | 505.6K | 138.9K | 3.71M | 63.76% | ↗ |
| 98 | 2014 | Michael Dinkins Executive Vice President Chief Financial Officer | 375.7K | — | 510.1K | 238.0K | 229.9K | 19.8K | 1.37M | 54.47% | ↗ |
| 99 | 2014 | Michael Dinkins Executive Vice President & Chief Financial Officer | 375.7K | — | 510.1K | 238.0K | 221.4K | 28.3K | 1.37M | 54.47% | ↗ |
| 100 | 2014 | Mauricio Arellano Executive Vice President, Global Operations | 336.6K | — | 457.3K | 213.4K | 206.0K | 15.3K | 1.23M | 54.59% | ↗ |
| 101 | 2014 | Mauricio Arellano Executive Vice President, Global Operations | 336.6K | — | 457.3K | 213.4K | 197.5K | 23.8K | 1.23M | 54.59% | ↗ |
| 102 | 2014 | Michelle Graham Senior Vice President, Human Resources | 266.7K | — | 611.9K | 148.8K | — | 17.0K | 1.04M | 72.84% | ↗ |
| 103 | 2014 | Andrew P. Holman Executive Vice President, Global Sales Marketing | 287.5K | — | 345.1K | 161.0K | 164.2K | 24.2K | 982.0K | 51.53% | ↗ |
| 104 | 2014 | Andrew P. Holman President, Corporate Development | 287.5K | — | 345.1K | 161.0K | 155.7K | 32.7K | 982.0K | 51.53% | ↗ |
| 105 | 2014 | Timothy G. McEvoy Senior Vice President, General Counsel Secretary | 248.5K | — | 156.2K | 72.9K | 131.8K | 80.4K | 689.8K | 33.20% | ↗ |
| 106 | 2014 | Timothy G. McEvoy Senior Vice President, General Counsel & Secretary | 248.5K | — | 156.2K | 72.9K | 123.7K | 88.5K | 689.8K | 33.20% | ↗ |
| 107 | 2014 | George Cintra Executive Vice President & Chief Technology Officer | 235.8K | — | 147.9K | 69.0K | 117.8K | 41.7K | 612.2K | 35.43% | ↗ |
| 108 | 2013 | Susan M. Bratton Former EVP Business Development | 261.1K | — | 873.8K | 815.1K | — | 1.76M | 3.71M | 45.58% | ↗ |
| 109 | 2013 | Thomas J. Hook President & Chief Executive Officer | 616.3K | — | 1.23M | 601.6K | 508.1K | 456.7K | 3.41M | 53.69% | ↗ |
| 110 | 2013 | Thomas J. Hook President Chief Executive Officer | 616.3K | — | 1.23M | 601.6K | 508.1K | 456.7K | 3.41M | 53.69% | ↗ |
| 111 | 2013 | Michael Dinkins Executive Vice President & Chief Financial Officer | 366.1K | — | 487.2K | 238.0K | 246.8K | 29.9K | 1.37M | 53.01% | ↗ |
| 112 | 2013 | Michael Dinkins Executive Vice President Chief Financial Officer | 366.1K | — | 487.2K | 238.0K | 246.8K | 29.9K | 1.37M | 53.01% | ↗ |
| 113 | 2013 | Michael Dinkins Senior Vice President | 366.1K | — | 487.2K | 238.0K | 246.8K | 29.9K | 1.37M | 53.01% | ↗ |
| 114 | 2013 | Mauricio Arellano Executive Vice President, Global Operations | 328.3K | — | 436.8K | 213.4K | 220.3K | 55.8K | 1.25M | 51.83% | ↗ |
| 115 | 2013 | Mauricio Arellano Executive Vice President, Global Operations | 328.3K | — | 436.8K | 213.4K | 220.3K | 55.8K | 1.25M | 51.83% | ↗ |
| 116 | 2013 | Michelle Graham Senior Vice President, Human Resources | 258.8K | — | 304.6K | 148.8K | 159.6K | 32.9K | 904.6K | 50.12% | ↗ |
| 117 | 2013 | Timothy G. McEvoy Senior Vice President, General Counsel Secretary | 242.9K | — | 149.2K | 72.9K | 138.1K | 99.7K | 702.8K | 31.60% | ↗ |
| 118 | 2013 | Timothy G. McEvoy Senior Vice President, General Counsel & Secretary | 242.9K | — | 149.2K | 72.9K | 138.1K | 99.7K | 702.8K | 31.60% | ↗ |
| 119 | 2013 | Andrew P. Holman Executive Vice President, Global Sales Marketing | 270.5K | 75.0K | 118.6K | 57.9K | 145.1K | 5.3K | 672.4K | 26.26% | ↗ |
| 120 | 2013 | Andrew P. Holman President, Corporate Development | 270.5K | 75.0K | 118.6K | 57.9K | 145.1K | 5.3K | 672.4K | 26.26% | ↗ |
| 121 | 2013 | George Cintra Executive Vice President & Chief Technology Officer | 222.0K | — | 97.3K | 47.5K | 101.8K | 32.7K | 501.3K | 28.88% | ↗ |
| 122 | 2012 | Thomas J. Hook President Chief Executive Officer | 546.0K | — | 1.82M | 586.9K | 296.5K | 333.5K | 3.58M | 67.17% | ↗ |
| 123 | 2012 | Mauricio Arellano Executive Vice President, Global Operations | 325.0K | — | 988.7K | 211.2K | 144.0K | 253.3K | 1.92M | 62.43% | ↗ |
| 124 | 2012 | Michael Dinkins Senior Vice President | 235.4K | — | 471.3K | 234.0K | 102.3K | 198.3K | 1.24M | 56.82% | ↗ |
| 125 | 2012 | Michael Dinkins Executive Vice President Chief Financial Officer | 235.4K | — | 471.3K | 234.0K | 102.3K | 198.3K | 1.24M | 56.82% | ↗ |
| 126 | 2012 | Susan M. Bratton Former EVP Business Development | 292.8K | — | 329.1K | 158.5K | 120.9K | 36.1K | 937.4K | 52.02% | ↗ |
| 127 | 2012 | Michelle Graham Senior Vice President, Human Resources | 250.0K | — | 298.5K | 143.7K | 101.6K | 23.8K | 817.7K | 54.09% | ↗ |
| 128 | 2012 | Timothy G. McEvoy Senior Vice President, General Counsel Secretary | 237.0K | — | 147.7K | 71.1K | 88.9K | 100.0K | 644.6K | 33.94% | ↗ |
| 129 | 2012 | Andrew P. Holman Executive Vice President, Global Sales Marketing | 185.6K | — | 100.0K | — | 32.4K | — | 318.0K | 31.44% | ↗ |
| 130 | 2012 | Susan M. Bratton President, Electrochem | — | — | — | — | — | — | — | — | ↗ |
| 131 | 2012 | Michael Dinkins | — | — | — | — | — | — | — | — | ↗ |
| 132 | 2012 | Thomas J. Mazza Former SVP Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 133 | 2012 | Mauricio Arellano President, Greatbatch Medical | — | — | — | — | — | — | — | — | ↗ |
| 134 | 2011 | Thomas J. Hook President Chief Executive Officer | 546.0K | — | 1.48M | 586.9K | 465.0K | 146.1K | 3.23M | 64.16% | ↗ |
| 135 | 2011 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 301.6K | — | 495.8K | 196.0K | 211.5K | 53.5K | 1.26M | 54.97% | ↗ |
| 136 | 2011 | Mauricio Arellano Executive Vice President, Global Operations | 325.0K | — | 447.7K | 211.2K | 227.9K | 39.2K | 1.25M | 52.67% | ↗ |
| 137 | 2011 | Susan M. Bratton Senior Vice President, Electrochem | 275.6K | — | 335.8K | 158.5K | 179.5K | 36.1K | 985.5K | 50.16% | ↗ |
| 138 | 2011 | Susan M. Bratton Former EVP Business Development | 275.6K | — | 335.8K | 158.5K | 179.5K | 36.1K | 985.5K | 50.16% | ↗ |
| 139 | 2011 | Michelle Graham Senior Vice President, Human Resources | 250.0K | 50.0K | 304.6K | 143.7K | 162.8K | 22.4K | 933.6K | 48.03% | ↗ |
| 140 | 2011 | Timothy G. McEvoy Senior Vice President, General Counsel Secretary | 237.0K | — | 150.7K | 71.1K | 142.5K | 41.7K | 643.0K | 34.49% | ↗ |
| 141 | 2011 | Mauricio Arellano President, Greatbatch Medical | — | — | — | — | — | — | — | — | ↗ |
| 142 | 2011 | Thomas J. Mazza Former SVP Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 143 | 2011 | Susan M. Bratton President, Electrochem | — | — | — | — | — | — | — | — | ↗ |
| 144 | 2010 | Susan H. Campbell Former Senior Vice President, Orthopaedic | 183.0K | — | 1.21M | 193.6K | — | 24.4K | 1.62M | 87.16% | ↗ |
| 145 | 2010 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 290.0K | — | 486.6K | 94.2K | 149.8K | 28.4K | 1.05M | 55.37% | ↗ |
| 146 | 2010 | Susan M. Bratton Senior Vice President, Electrochem | 265.0K | — | 393.3K | 76.2K | 127.1K | 34.8K | 896.5K | 52.37% | ↗ |
| 147 | 2010 | Michelle Graham Senior Vice President, Human Resources | 14.4K | 150.0K | 450.0K | — | — | — | 614.4K | 73.24% | ↗ |
| 148 | 2010 | Thomas J. Hook President Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 149 | 2010 | Susan M. Bratton President, Electrochem | — | — | — | — | — | — | — | — | ↗ |
| 150 | 2010 | Michelle Graham Senior Vice President, Human Resources | — | — | — | — | — | — | — | — | ↗ |
| 151 | 2010 | Mauricio Arellano President, Greatbatch Medical | — | — | — | — | — | — | — | — | ↗ |
| 152 | 2010 | Thomas J. Mazza Former SVP Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 153 | 2009 | Thomas J. Hook President Chief Executive Officer | 491.6K | — | 356.2K | 904.2K | 318.6K | 143.1K | 2.21M | 56.94% | ↗ |
| 154 | 2009 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 271.5K | — | 104.9K | 251.8K | 153.9K | 83.6K | 865.7K | 41.20% | ↗ |
| 155 | 2009 | Mauricio Arellano Senior Vice President, Cardiac Neurology | 267.5K | — | 87.1K | 201.9K | — | 37.8K | 735.1K | 39.31% | ↗ |
| 156 | 2009 | Mauricio Arellano President, Greatbatch Medical | 267.5K | — | 87.1K | 201.9K | 140.8K | 37.8K | 735.1K | 39.31% | ↗ |
| 157 | 2009 | Susan M. Bratton Senior Vice President, Electrochem | 250.2K | — | 84.6K | 196.1K | 131.7K | 65.7K | 728.3K | 38.54% | ↗ |
| 158 | 2009 | Susan M. Bratton Senior Vice President, Electrochem Solutions | 250.2K | — | 84.6K | 196.1K | — | 65.7K | 728.3K | 38.54% | ↗ |
| 159 | 2009 | Susan H. Campbell Senior Vice President, Orthopaedic | 267.5K | — | 87.1K | 201.9K | — | 19.8K | 717.1K | 40.30% | ↗ |
| 160 | 2009 | Susan H. Campbell Former Senior Vice President, Orthopaedic | 267.5K | — | 87.1K | 201.9K | 140.8K | 19.8K | 717.1K | 40.30% | ↗ |
| 161 | 2008 | Thomas J. Hook President Chief Executive Officer | 475.0K | — | 363.8K | 1.20M | 431.3K | 50.8K | 2.52M | 61.96% | ↗ |
| 162 | 2008 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 262.2K | — | 107.1K | 330.0K | 208.3K | 91.0K | 998.6K | 43.77% | ↗ |
| 163 | 2008 | Susan M. Bratton Senior Vice President, Electrochem Solutions | 241.7K | — | 86.4K | 255.6K | — | 92.7K | 854.6K | 40.01% | ↗ |
| 164 | 2008 | Susan M. Bratton Senior Vice President, Electrochem | 241.7K | — | 86.4K | 255.6K | 178.3K | 92.7K | 854.6K | 40.01% | ↗ |
| 165 | 2008 | Susan M. Bratton Senior Vice President, Commercial | 241.7K | — | 147.6K | 171.4K | 178.3K | 92.7K | 831.7K | 38.36% | ↗ |
| 166 | 2008 | Mauricio Arellano President, Greatbatch Medical | 248.8K | — | 88.9K | 263.1K | 183.5K | 30.9K | 815.2K | 43.18% | ↗ |
| 167 | 2008 | Mauricio Arellano Senior Vice President, Cardiac Neurology | 248.8K | — | 88.9K | 263.1K | — | 30.9K | 815.2K | 43.18% | ↗ |
| 168 | 2008 | Susan H. Campbell Former Senior Vice President, Orthopaedic | 248.8K | — | 88.9K | 263.1K | 183.5K | 21.8K | 806.1K | 43.66% | ↗ |
| 169 | 2008 | Susan H. Campbell Senior Vice President, Orthopaedic | 248.8K | — | 88.9K | 263.1K | — | 21.8K | 806.1K | 43.66% | ↗ |
| 170 | 2008 | Susan H. Campbell Senior Vice President, Orthopaedics | 248.8K | — | 149.3K | 176.5K | 183.5K | 21.8K | 779.9K | 41.77% | ↗ |
| 171 | 2007 | Thomas J. Hook President Chief Executive Officer | 448.2K | — | 321.1K | 884.0K | — | 41.5K | 2.22M | 54.23% | ↗ |
| 172 | 2007 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 248.0K | — | 367.9K | 208.2K | — | 76.0K | 1.14M | 50.44% | ↗ |
| 173 | 2007 | Mauricio Arellano Senior Vice President, Cardiac Neurology | 229.0K | — | 337.9K | 239.6K | — | 76.1K | 1.11M | 52.23% | ↗ |
| 174 | 2007 | Susan M. Bratton Senior Vice President, Electrochem Solutions | 229.0K | — | 337.9K | 191.2K | — | 72.1K | 1.05M | 50.23% | ↗ |
| 175 | 2007 | Susan H. Campbell Senior Vice President, Orthopaedic | 229.0K | — | 337.9K | 215.4K | — | 16.0K | 1.02M | 54.17% | ↗ |
| 176 | 2007 | Susan M. Bratton Senior Vice President, Commercial | 229.0K | — | 86.4K | 120.3K | 223.2K | 72.1K | 731.0K | 28.28% | ↗ |
| 177 | 2007 | Susan H. Campbell Senior Vice President, Orthopaedics | 229.0K | — | 87.5K | 131.2K | 223.2K | 16.0K | 686.7K | 31.84% | ↗ |
| 178 | 2006 | Thomas J. Hook President Chief Executive Officer | 378.6K | — | 168.4K | 356.3K | 646.0K | 49.5K | 1.60M | 32.82% | ↗ |
| 179 | 2006 | Thomas J. Mazza Senior Vice President Chief Financial Officer | 215.7K | — | 20.0K | 112.0K | 292.6K | 40.1K | 680.4K | 19.41% | ↗ |
| 180 | 2006 | Susan M. Bratton Senior Vice President, Commercial | 205.8K | — | 22.1K | 90.6K | 254.4K | 70.7K | 643.6K | 17.51% | ↗ |
| 181 | 2006 | Mauricio Arellano Senior Vice President, Cardiac Neurology | 201.8K | — | 19.6K | 94.5K | 254.4K | 27.1K | 597.4K | 19.09% | ↗ |
| 182 | 2006 | Susan H. Campbell Senior Vice President, Orthopaedics | 205.8K | — | 21.4K | 98.5K | 254.4K | 14.8K | 594.8K | 20.16% | ↗ |
| 183 | 2005 | Edward F. Voboril Chairman of the Board and Chief Executive Officer | 430.0K | 817.0K | — | — | — | — | 1.25M | 0.00% | ↗ |
| 184 | 2005 | Thomas J. Hook President and | 339.4K | 595.0K | — | — | — | — | 934.4K | 0.00% | ↗ |
| 185 | 2005 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 240.0K | 384.0K | — | — | — | — | 624.0K | 0.00% | ↗ |
| 186 | 2005 | Thomas J. Mazza Senior Vice President and Chief Financial Officer | 193.8K | 291.4K | — | — | — | — | 485.2K | 0.00% | ↗ |
| 187 | 2005 | Marco F. Benedetti | 133.8K | 99.9K | — | — | — | — | 233.7K | 0.00% | ↗ |
| 188 | 2004 | Edward F. Voboril Chairman of the Board, President and | 416.9K | 100.0K | 5.0K | 61.5K | — | 14.3K | 536.2K | 12.40% | ↗ |
| 189 | 2004 | Edward F. Voboril Chairman of the Board and Chief Executive Officer | 416.9K | 100.0K | — | — | — | — | 516.9K | 0.00% | ↗ |
| 190 | 2004 | Lawrence P. Reinhold Executive Vice President and Chief Financial Officer | 318.3K | 170.1K | 1.0K | 12.3K | — | 14.3K | 503.7K | 2.64% | ↗ |
| 191 | 2004 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 239.2K | 129.0K | — | — | — | — | 368.2K | 0.00% | ↗ |
| 192 | 2004 | Thomas J. Mazza Vice President and | 175.0K | 79.6K | 200.00 | 2.8K | — | 12.4K | 267.2K | 1.12% | ↗ |
| 193 | 2004 | Thomas J. Mazza Senior Vice President and Chief Financial Officer | 175.0K | 79.6K | — | — | — | — | 254.6K | 0.00% | ↗ |
| 194 | 2004 | Thomas J. Hook President and | 103.8K | 75.0K | — | — | — | — | 178.8K | 0.00% | ↗ |
| 195 | 2004 | Thomas J. Hook President Chief Executive Officer | 103.8K | — | 5.0K | 50.0K | — | 7.0K | 115.8K | 47.51% | ↗ |
| 196 | 2003 | Edward F. Voboril Chairman of the Board, President and | 356.8K | 495.0K | 5.0K | 67.5K | — | 14.2K | 871.0K | 8.32% | ↗ |
| 197 | 2003 | Edward F. Voboril Chairman of the Board and Chief Executive Officer | 356.8K | 495.0K | — | — | — | — | 851.8K | 0.00% | ↗ |
| 198 | 2003 | Edward F. Voboril Chairman of the Board and Chief Executive Officer | 356.8K | 495.0K | — | — | — | — | 851.8K | 0.00% | ↗ |
| 199 | 2003 | Jose E. Almeida | 283.8K | 351.7K | — | — | — | — | 635.5K | 0.00% | ↗ |
| 200 | 2003 | Lawrence P. Reinhold Executive Vice President and Chief Financial Officer | 285.2K | 332.1K | 1.0K | 13.5K | — | 14.2K | 632.5K | 2.29% | ↗ |
| 201 | 2003 | Lawrence P. Reinhold Executive Vice President and Chief Financial Officer | 285.2K | 332.1K | — | — | — | — | 617.3K | 0.00% | ↗ |
| 202 | 2003 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 214.6K | 243.6K | — | — | — | — | 458.2K | 0.00% | ↗ |
| 203 | 2003 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 214.6K | 243.6K | — | — | — | — | 458.2K | 0.00% | ↗ |
| 204 | 2003 | Curtis F. Holmes, Ph.D. Group Vice President, Medical Components | 219.5K | 223.6K | — | — | — | — | 443.1K | 0.00% | ↗ |
| 205 | 2003 | Thomas J. Mazza Vice President and | 26.9K | 20.0K | — | 4.7K | — | 1.3K | 48.3K | 9.66% | ↗ |
| 206 | 2003 | Thomas J. Mazza Senior Vice President and Chief Financial Officer | 26.9K | 20.0K | — | — | — | — | 46.9K | 0.00% | ↗ |
| 207 | 2002 | Edward F. Voboril Chairman of the Board, President and | 351.3K | 100.0K | 25.0K | 83.1K | — | 40.2K | 516.5K | 20.92% | ↗ |
| 208 | 2002 | Curtis F. Holmes, Ph.D. Group Vice President, Medical Components | 201.7K | 45.0K | — | — | — | 40.2K | 286.9K | 0.00% | ↗ |
| 209 | 2002 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 181.0K | 50.0K | 4.5K | 19.3K | — | 38.3K | 273.8K | 8.71% | ↗ |
| 210 | 2002 | V.W. Brinkerhoff III Group Vice President, | 165.9K | 40.0K | — | — | — | 24.4K | 230.3K | 0.00% | ↗ |
| 211 | 2002 | Lawrence P. Reinhold Executive Vice President and Chief Financial Officer | 153.4K | 45.0K | 1.0K | 82.3K | — | 17.6K | 217.0K | 38.40% | ↗ |
| 212 | 2002 | Lawrence P. Reinhold Executive Vice President and Chief Financial Officer | 153.4K | 45.0K | — | — | — | 17.6K | 216.0K | 0.00% | ↗ |
| 213 | 2001 | Edward F. Voboril Chairman of the Board, President and Chief Executive Officer | 335.0K | 345.0K | — | 15.4K | — | 27.1K | 707.1K | 2.18% | ↗ |
| 214 | 2001 | Edward F. Voboril Chairman of the Board, President and | 335.0K | 345.0K | — | — | — | 27.1K | 707.1K | 0.00% | ↗ |
| 215 | 2001 | Richard W. Mott Executive Vice President and Chief Operating Officer | 195.0K | 110.0K | — | 6.4K | — | 17.9K | 322.9K | 1.97% | ↗ |
| 216 | 2001 | Curtis F. Holmes, Ph.D. Group Vice President, Medical Components | 193.9K | 85.0K | — | — | — | 16.0K | 294.9K | 0.00% | ↗ |
| 217 | 2001 | Curtis F. Holmes, Ph.D. Group Vice President, Components and President, Greatbatch-Hittman, Inc. | 193.9K | 85.0K | — | 6.6K | — | 16.0K | 294.9K | 2.25% | ↗ |
| 218 | 2001 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 170.0K | 85.5K | — | 5.0K | — | 16.2K | 271.7K | 1.84% | ↗ |
| 219 | 2001 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 170.0K | 85.5K | — | — | — | 16.2K | 271.7K | 0.00% | ↗ |
| 220 | 2001 | Peter E. Samek Vice President, Corporate Development | 164.9K | 62.0K | — | 10.0K | — | 3.5K | 230.4K | 4.34% | ↗ |
| 221 | 2001 | V.W. Brinkerhoff III Group Vice President, | 51.9K | 15.0K | — | — | — | 1.1K | 68.0K | 0.00% | ↗ |
| 222 | 2000 | Edward F. Voboril Chairman of the Board, President and | 315.0K | 105.0K | — | — | — | 20.6K | 440.6K | 0.00% | ↗ |
| 223 | 2000 | Edward F. Voboril Chairman of the Board, President and Chief Executive Officer | 315.0K | 105.0K | — | 21.0K | — | 20.6K | 440.6K | 4.78% | ↗ |
| 224 | 2000 | Curtis F. Holmes, Ph.D. Group Vice President, Components and President, Greatbatch-Hittman, Inc. | 184.4K | 45.7K | — | 7.9K | — | 164.9K | 395.0K | 2.00% | ↗ |
| 225 | 2000 | Curtis F. Holmes, Ph.D. Group Vice President, Medical Components | 184.4K | 45.7K | — | — | — | 164.9K | 395.0K | 0.00% | ↗ |
| 226 | 2000 | Richard W. Mott Executive Vice President and Chief Operating Officer | 161.3K | 41.0K | — | 7.9K | — | 10.5K | 212.8K | 3.70% | ↗ |
| 227 | 2000 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 150.3K | 30.6K | — | — | — | 10.8K | 191.8K | 0.00% | ↗ |
| 228 | 2000 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 150.3K | 30.6K | — | 5.6K | — | 10.8K | 191.8K | 2.91% | ↗ |
| 229 | 2000 | Peter E. Samek Vice President, Corporate Development | — | — | — | — | — | — | — | — | ↗ |
| 230 | 1999 | Edward F. Voboril Chairman of the Board, President and Chief Executive Officer | 271.5K | 253.1K | — | 40.9K | — | 23.3K | 547.9K | 7.47% | ↗ |
| 231 | 1999 | Curtis F. Holmes, Ph.D. Group Vice President, Components and President, Greatbatch-Hittman, Inc. | 147.2K | 38.4K | — | 8.9K | — | 185.7K | 371.2K | 2.41% | ↗ |
| 232 | 1999 | Richard W. Mott Executive Vice President and Chief Operating Officer | 138.3K | 39.7K | — | 8.9K | — | 18.7K | 196.7K | 4.52% | ↗ |
| 233 | 1999 | Larry T. DeAngelo Senior Vice President, Administration and Secretary | 128.6K | 36.9K | — | 6.5K | — | 18.4K | 183.9K | 3.53% | ↗ |
| 234 | 1999 | Peter E. Samek Vice President, Corporate Development | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph W. Dziedzic | Advisor | 3M | male |
| Payman Khales | Chief Executive Officer, President & Director | 1M | male |
| Andrew Senn | President of Cardio & Vascular | 908.0K | male |
| Diron Smith | Executive Vice President & Chief Financial Officer | 844.1K | male |
| John Harris | Executive Vice President of Global Operations & Manufacturing Strategy | 822.7K | male |
| Kirk K. Thor | Executive Vice President & Chief Human Resources Officer | 791.6K | male |
| Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | 742.8K | male |
| Lindsay Krause Blackwood | Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 619.0K | female |
| Kristen Marie Stewart | Director of Investor Relations | — | female |
| Carol Russell | Vice President & Chief Information Officer | — | female |
| Sanjiv Arora | Senior Vice President of Strategy, Business Development and Investor Relations | — | male |
| Tom Thomas | Vice President, Corporate Controller & Principal Accounting Officer | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ITGR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
